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ABSTRACT
DEVELOPMENT AND CHARACTERIZATION OF A BIOPOLYMER DIRECTWRITE PROCESS FOR 3D MICROVASCULAR STRUCTURES FORMATION
Xiaoming Fan
June 21, 2019

Engineering of bulk tissues has been limited by the lack of nutrient and
waste exchange in these tissues without an adjacent capillary network. To produce
microvasculature, a scaffold must be produced that provides temporary
mechanical support and stimulate endothelial cell adhesion, growth, and
morphogenesis into a vessel. However, current well-established techniques for
producing microvasculature, such as electrospinning, are limited since they lack
both the precision to control fiber placement in three-dimensional space and the
ability to create fiber networks with predefined diameters to replicate the
physiological microvascular progression from arteriole to capillary to venule. Our
group has developed a “Direct-write” technique using a 3-Axis robotic dispensing
system to process polymers into precisely positioned, three-dimensional,
suspended fibers with controlled diameters.

vi

Within this dissertation, a conceptual scaffold-covering strategy is
presented for the formation of the precisely positioned, three-dimensional
microvascular structure with a controlled diameter in vitro. This study considers
ways to extend the 3-Axis robotic dispensing system by incorporating new
biodegradable materials into micro-fibers. First, a number of different biopolymers
(natural, synthetic, composites, and copolymers) were used for demonstrating the
capability

of

direct-writing

micro-fibers

and

branched

structures

with

microvascular-scale diameter through the 3-Axial robotic dispensing system. Then,
the fabrication process was characterized by a design of experiments and a
generalized mathematical model was developed through dimensional analysis.
The empirical model determined the correlation between polymer fiber diameter
and intrinsic properties of the polymer solution together with the processing
parameters of the robotic dispensing system and allows future users the ability to
employ the 3-Axis robotic dispensing system to direct-write micro-fibers without
trial-and-error work. This study also considers ways to broaden the prevascularization methods by covering Human Dermal Microvascular Endothelial
Cells (HDMECs) on the fabricated scaffold to generate the microvascular structure.
HDMECs cultured on the produced micro-fiber scaffolds were observed to form a
confluent monolayer spread along the axis and around the circumference of the
fibers within two days of seeding. Once confluency was reached, the cell-covered
scaffold was embedded into a collagen gel and a hybrid structure was formed.
Through these experiments, we demonstrate the ability to obtain a cell-viable,
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flexible, and free-standing “modular tissue”, which could be potentially assembled
to a three-dimensional microvascular network through angiogenesis mechanism.
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CHAPTER 1: INTRODUCTION

Tissue and organ failure caused by disease or injury has become a major
health dilemma in the world, accounting for ~40% of the annual total causes of
death in 2015 [1]. There are four principal therapeutic strategies for treating tissue
and organ failure in patients: surgical repair, artificial prostheses, mechanical
devices, and transplantation (human or xenotransplantation) [2]. Although these
therapies have saved innumerable patients' lives, they are still far from perfect
solutions. A surgical repair usually leads to long-term complications for the patient.
For example, hepatic resection often develops serious postoperative morbidity, the
most common being bile leak and associated perihepatic abscess [3]. Artificial
prostheses and mechanical devices neither perform the full physiological function
nor adequately repair/restore full organ function. Moreover, artificial prostheses
and mechanical devices are generally subjected to wear upon long-term
implantation, which can induce an inflammatory response in the patient [4]. For
some patients with end-stage organ failure, such as heart and liver failure,
transplantation is the most effective way to save their lives. However, organ
transplantation suffers from severe donor shortage. Specifically, according to
Organ Procurement and Transplantation Network Data Reports, there are
116,000+ patients on the national transplant waiting list as of August 2017. Only
33,611 transplants were performed in 2016, and the vast imbalance between the
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number of organ donors and patients waiting for donor transplants worsens every
year [5].
Tissue engineering is an approach with significant potential for solving the
organ donor shortage problem. The concept of tissue engineering was first
introduced by Robert Langer and Joseph Vacanti in the first NSF-sponsored
meeting on tissue engineering in 1988, which described the concept as “attaching
cell preparations to bioerodable artificial polymers in cell culture and then
implanting this polymer-cell scaffold into animals” [6]. In 1993, the pioneering paper
entitled “Tissue Engineering” appeared in Science, which further defined tissue
engineering as “an interdisciplinary field that applies the principles of engineering
and the life sciences toward the development of biological substitutes that restore,
maintain, or improve tissue function” [7]. The main goal of tissue engineering is to
create functional tissues and organs in vitro and then transplant them into the host.
After decades of rapid development, scientists and engineers have begun to
design and engineer vital organs/structures in the laboratory, including the liver,
spinal cord, blood vessels, cartilages, hearts valves, skin, bones, intestines,
urological structures, tendons, and muscles [8-12]. Overall, most engineered
tissues have not realized commercial success, primarily due to the need for a
sustainable, highly branched system of blood vessels and microvascular network
to enable the exchange of nutrients and waste products. Only a few engineered
tissues, such as skin and cartilage [13-18] have been successful clinically since
they can be manufactured without vascular or neural networks. However, progress
on producing larger and more complex tissues and organs has hampered by the
2

lack of ability to create engineering microvascular network that meet the metabolic
needs of the tissues after implantation [19-21].
Thus, the capability to selectively produce a microvascular network has
become an emerging field of tissue engineering. Both in vivo and in vitro methods
have been proposed for the development of the engineered microvasculature.
Vasculogenesis and angiogenesis are the two fundamental processes involved in
new blood vessel formation in vivo [22, 23]. There are three different models that
have been studied in vivo to form microvascular lumen: (1) vacuole formation and
coalescence, (2) wrapping around extracellular space, and (3) cell death and
phagocytosis [24]. This research may answer many important questions about
microvasculature development, such as how endothelial cells could form a luminal
or apical plasma membrane and how existing plasma membranes could rearrange
to form a vascular lumen. However, in vivo studies are time-consuming and highcost. Also, the biology of animals, mostly mice[25], is different from humans and
the rejection reaction could be a severe problem.
Due to these complications, several methods that have been developed to
generate microvasculature in vitro. The idea of prevascularization was first
reported by Mikos et al. in 1993 [26], with the main concept being to incorporate
endothelial cells into decellularized tissue or an ECM [27-30]. However, the
network patterns of microvasculature were usually formed randomly and the
diameters of the produced vessels were uncontrollable. Another strategy to
generate blood vessels in vitro is to create lumen structures via microfluidics or
bio-ink three-dimensional printing techniques[31-33]. Although a microvascular
3

network with desired design pattern could be formed, most of these techniques
suffered from an unrealistic minimum lumen diameter (several hundred microns)
or non-cylindrical shapes that are dissimilar to natural forming microvasculature in
the body.
With the advent of biopolymers, a fiber scaffold could be used to support
and guide endothelial cells to generate a microvascular network in vitro. Currently,
traditional techniques such as dry spinning, wet spinning, and electrospinning are
employed to produce a variety of fibrous structures including suspended
microfibers, fibrous monoliths, porous films, and nano-fibrous mats. However, the
limitations on the accurate placement of fibers to predefined locations with
controlled diameters have impeded the further advancement of these types of
microvascular networks. Thus, developing a three-dimensional microvascular
scaffold with a specific pattern and biomimetic diameter to provide temporary
mechanical support and stimulate endothelial cell adhesion, growth and
morphogenesis into a vessel would be beneficial. Our research group has
developed a “Direct-write” method using a 3-Axis robotic dispensing system to
fabricate suspended micron/sub-micron polymer fibers. The driving mechanism
behind this process harnesses the surface tension of liquid bridges to promote the
controlled thinning of a macroscale polymer solution ﬁlament into the desired
microscale ﬁbers. The advantage of this process is the ease of obtaining arrays of
precisely-positioned fibers with controllable diameters in three-dimensional space.
Several scaffold design criteria should be met: (1) The scaffold size and spatial
position should be controlled within the microvascular scale. (2) The scaffold must

4

be capable of adhering and proliferating the endothelial cells. (3) The scaffold must
be robust enough to remain during cell proliferation so as to allow a monolayer of
endothelial cells to be formed and supported by ECM. (4) The scaffold should
degrade in a reasonable time to develop the final capillary network.

1.1 Purpose of the Study
The overall goal of this project was to develop a model for the construction
of a precisely positioned, three-dimensional, suspended biopolymer scaffold with
controlled diameters and a proof-of-concept of a physiological microvascular
networks in vitro. The studies presented in this work focus on: (1) direct-writing the
three-dimensional

oriented

biopolymer

scaffold

with

microvascular-scale

diameters by using a 3-Axis robotic dispensing system; (2) developing and
validating an empirical model of the direct-write process based on a design of
experiment, characterization, and dimensional analysis; (3) determining a recipe
for seeding the Human Dermal Microvascular Endothelial Cells (HDMECs) on the
fabricated scaffold to form a confluent HDMECs monolayer; and (4) embedding
the HDMECs-covered scaffold into the collagen hyrogel to form a vascularized
sheet in order to demonstrate the conceptual “modular tissue”, which could be
potentially assembled to bulk tissue.

1.2 Specific Aims
The specific aims for this project are:
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Specific Aim 1: To fabricate precisely-positioned, suspended micro-fibers
and branch structures with microvascular-scale diameters. These micro-fibers and
branch structures will be fabricated from a variety of biodegradable polymers via
the direct-write technique.
Specific Aim 2: To generate and validate an empirical dimensionless
model of the direct-write process. Gelatin will be used to perform a design of
experiment and characterization for the empirical dimensionless model generation.
Poly(Lactic-co-glycolic acid) (PLGA), gelatin/PLGA composites, Polylactic acid
(PLA), and Polylactic acid- Polyethylene glycol (PLA-PEG) copolymer will be used
to validate the empirical dimensionless model.
Specific Aim 3: To seed the endothelial cells on the selected scaffold by
following the scaffold-covering strategy. HDMECs will be used to grow a confluent
monolayer on the surface of the scaffold. The monolayer should spread along the
axis and around the circumference of the fiber.
Specific Aim 4: To encapsulate the cell-covered scaffold into ECM and
continue to culture to obtain the vascularized sheet. Type I collagen from rat tail
will be used as the ECM. The scaffold degradation and Cell-Scaffold-ECM
interaction will be evaluated through various imaging techniques.

1.3 Significance of the Study
This project aims to generate a conceptual solution for creating a threedimensional microvascular network in vitro. In this project, a biodegradable
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microvascular scaffold will be developed and fabricated by integrating direct-write
technique through a 3-axis robotic dispensing system. The fabrication will be
characterized and an empirical model will be generated to predict the scaffold
diameters. Instead of using human umbilical vein endothelial cells (HUVECs) in
the most reported prevascularization research, Human Dermal Microvascular
Endothelial Cells (HDMECs) will be chosen because they have a real common
origin with human blood and lymphatic capillaries. HDMECs will be seeded on the
scaffold, and a confluent monolayer will be formed on the surface of the scaffold.
ECM will be added to support the endothelial cells and form a cell-viable, flexible,
and free-standing vascularized sheet, which could be potentially assembled to a
three-dimensional microvascular network. To date, the combination of using the
direct-write technique to fabricate biopolymer scaffold and create a microvascular
network by scaffold-covering strategy has not been reported.
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CHAPTER 2: BACKGROUND
2.1 Overview of the Microcirculation System
Microcirculation is one of the most essential components in the human
circulation system, and 84% of systemic circulation occurs here. The primary
function of the microcirculation system is to transport nutrients to the tissues and
removal of cell excreta[34, 35]. The microcirculation system is ubiquitously
distributed in our bodies, and the peripheral circulation has about 10 billion
capillaries. The estimated surface area of these capillaries may cover 1/8 of a
standard US football field (500 to 700 m2). Most of the functional live cells of the
body are in about 20 to 30 micrometers away from a capillary[34]. Cells too distant
(> ~200µm) from capillary would not survive and proliferate due to the lack of the
supply of oxygen and nutrients[36].
2.1.1 Structure of the Capillary System
In general, the capillary system consists of three primary components: 1)
Arterioles – artery will form 6 to 8 branches after entering an organ and become
smaller, which generally have internal diameters of 20 to 40 micrometers. 2)
Capillary – arterioles further branch 2 to 5 times, leading to only 5 to 10
micrometers at their ends. 3) Venules – capillaries converge together to form small
vessels before exiting an organ and connecting to the vein. The venules are
usually smaller than arterioles in diameter. The typical arrangement of the capillary
bed is shown in Figure 2.1. The arterioles have a robust muscular coat, and they
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are expandable and contractile thus they can control the blood flow into each tissue.
The terminal arterioles, also known as metarterioles are encircled by smooth
muscle fibers at the intermittent points. The muscular coat is not continuous in
metarterioles. The capillaries also encompassed by smooth muscle fibers just like
metarterioles. This configuration is defined as precapillary sphincter, and it can
control the entrance of the capillary. Although the venules are not very muscular
like arterioles, they can still expense and contract due to lower pressure in
venules[34, 35].

Figure 2. 1 Illustration of the structure of the capillary bed. Source:[37]

2.1.2 Structure of the Vessel Wall
Arterioles are the smallest arteries, and their structures are often simple.
Arterioles have a poorly-defined tunica externa. In some larger arterioles, the
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tunica media is consists of one or two layers smooth muscles cells with thickness
~20µm[35]. In contrast, the tunica of the smaller arterioles has scattered smooth
muscle cells with incomplete cell layer. Venules have similar structures as
arterioles, generally with no elastic tissue and less smooth muscles and fibrous
tissue. The capillary wall is constructed of single-layer endothelial cells, and the
endothelial cells are surrounded by a basement membrane on the outside.
Capillaries are extremely thin (~0.5 micrometers) and permeable, thus the
nutrients and wastes can be exchanged between circulation systems and the
cells[34]. The summary and comparison of these three vessels in microcirculation
is shown in Table 2.1[38].
Table 2. 1 Summary and comparison of blood vessel anatomy. Source:[38]
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2.1.3 Structure of the Capillary Wall
As now we know endothelial cell layer exists in all the microcirculation
vessels, a further study of the capillary wall could help us to understand the
structure and mechanism for the tissue engineering better. Figure 2.2 is an
illustration of the structure of the capillary wall. Small “slit pores” with average width
about 6 to 7 nanometers could be found between two adjacent endothelial cells,
known as intercellular cleft. The cleft connects endothelial cells together by a tiny
protein bridge, and the thin slit could make sure fluid can freely flow through it. The
many small caves in endothelial cells are plasmalemmal vesicles. The real
functions of these caves are still not clear, and some studies show they involve
transporting nutrients molecules across endothelial cells’ membrane[34].

Figure 2. 2 Illustration of the structure of the capillary wall. Source: [34]
In general, there are three types of capillaries according to the degree of
permeability caused by different structures: 1) Continuous Capillaries – Most
common capillaries that could found in muscle and skin. The intercellular clefts are
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very small to ensure the least permeability. 2) Fenestrated capillaries – Often found
in kidneys and small intestines where a high rate of exchange is needed. The
relatively large pores make sure small molecules could pass through the
membrane. 3) Sinusoidal capillary – Specifically found in liver, bone marrow, and
spleen which are usually loose structures. The intercellular clefts are wide enough
to pass through the entire cells. All three types of capillaries are shown in Figure
2.3. The blood-brain barrier is an exception that the endothelial cells have no
intercellular clefts and tight junctions are encircled by the whole capillary. Only a
few selected vital molecules could pass through the membrane.

Figure 2. 3 Illustration of three structures of capillaries: continuous capillary,
fenestrated capillary, and sinusoid capillary. Source: [37]

2.1.4 Function of the Capillary System
Instead of flowing continuously in the artery and vein, blood flows
intermittently in the capillary system. The intermittent contraction of metarterioles
and precapillary sphincters control the capillaries open and shut every few seconds
12

or minutes. The most important function of the capillary system is to exchange
water, nutrients, and other substances between the blood and interstitial fluid, and
the most efficient way to exchange is diffusion. Figure 2.4 is showing blood flows
through the capillary’s lumen, and countless water molecules and dissolved
nutrients diffuse in and out through the capillary wall. Different molecules may have
different diffusion paths because of the molecules’ sizes, properties, and
concentrations. Such as lipid-soluble molecules directly diffuse through the
capillary wall, whereas water-soluble substances diffuse through the holes of the
intercellular “pores” in the capillary’s membrane.

Figure 2. 4 Diffusion of fluid molecules between the capillary and interstitial fluid
space. Source: [34]
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2.1.5 Endothelial Cell
As we discussed before, the endothelial cells are the most fundamental
component of the microcirculation system. They differ in structures and functions
according

to

their

ubiquitousness

in

different

vascular

locations

and

microenvironments[39, 40]. We could briefly classify endothelial cells into two
categories: (1) Large vessels endothelial cells, and (2) Microvascular endothelial
cells. Microvascular endothelial cells will be discussed in this work since we are
trying to engineer the capillary network. One significant property of the
microvascular endothelial cell is that they are highly active and intimately involved
in numerous physiological processes. The list of the common commercially available endothelial cell is shown in Table 2.2.
Table 2. 2 List of common commercially-available endothelial cells. Source:[41]
Cell type

Common source

Examples
Human Umbilical Vein Endothelial Cells
(HUVEC),
Human Umbilical Artery Endothelial Cells

Large

Umbilical vein and

vessels

artery, the aorta, the

endothelial

coronary artery, and

cells

the pulmonary artery Human Coronary Artery Endothelial Cells

(HUAEC),
Human Aortic Endothelial Cells (HAoEC),

(HCAEC)
Human Pulmonary Artery Endothelial Cells
(HPAEC)
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Human Dermal Microvascular (HDMEC),
Human Cardiac Microvascular Endothelial
Microvascular Dermal, lung,

Cells (HCMEC),

endothelial

cardiac and uterine

Human Pulmonary Microvascular

cells

tissues

Endothelial Cells (HPMEC),
Human Uterine Microvascular Endothelial
Cells (HUtMEC)

2.2. Extracellular Matrix
Extracellular matrix (ECM) are ubiquitous noncellular components that
could be found in almost all the tissues and organs. The ECM not only acts as a
three-dimensional structural scaffold for cells, but also functions as an adhesive
substrate, presents, sequesters, and stores growth factors, senses and transduces
mechanical signal, and serves as signals for morphogenesis and differentiation[42,
43]. Fundamentally, the ECM is composed of water and various macromolecules.
Those macromolecules have been classified into two main groups by composition:
Proteoglycans and Fibrous proteins [44, 45]. More than 30 different proteoglycans
are known in humans, most of which are composed of glycosaminoglycans
(unbranched polysaccharide chains) that are covalently linked to a specific core
protein. According to their core protein, the proteoglycans could be classified as
three groups: Modular proteoglycans, Small leucine-rich proteoglycans (SLRPs),
and Cell-surface proteoglycans (Figure 2.5) [46]. The formed glycosaminoglycans
hydrogel fill the majority of the extracellular interstitial space. Recently studies
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suggest that proteoglycans play a prominent role in a wide variety of functions,
such as buffering, hydration, signaling, resisting compressive force, and binding
growth factors[45, 47, 48].
Fibrous proteins could be classified as collagens, fibronectins, elastins, and
laminins(Figure 2.5) [45, 49]. Among those, collagens are the most common
fibrous proteins found in the ECM, and more than 28 different types of collagen
have been identified in the human body so far. Collagen could provide tensile
strength, regulate cell adhesion, and direct tissue development[43]. A typical
collagen molecule has a complex hierarchical structure that contains a signature
triple-helix structure (300 nm in length and 1.5 nm in diameter). The collagen
molecules could form fibrils and networks depending on the types of collagen.
Type I, II, III, V, and XI could self-assemble into fibrils that can resist shear, tensile,
and pressure force, whereas type IV, VIII, and X could form networks which are
incorporated into the basement membrane[47].
Fibronectin is another important non-collagenous fibrous protein. The
fibronectin molecules are usually composed of multiple chains, each encoded by
single genes. Fibronectin could be stretched many folds over its resting length by
cellular traction force, and it could also direct the organization of the interstitial
ECM[45, 50]. In addition, the adhesive Arg-Gly-Asp (RGD) sequence could be
found in the hydrophilic loop of fibronectin. Thus, fibronectin could also act as an
adhesive substrate for cell and other matrix proteins due to the fact that RGD
sequences are critical for recognition and binding to many integrins [43].
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Recently studies suggest that ECM play an essential role in both
angiogenesis and vasculogenesis. During the blood vessel generation process,
the endothelial cells migrate, proliferate, and eventually form the lumen structure
in the ECM[51]. Researchers have proved that integrin receptors of the ECM play
a critical role in regulating the cell shape through the change in the cytoskeleton
and forming the lumen shape via the difference in the cell-cell interactions[51, 52].
Several in-vitro studies have demonstrated that the endothelial cells could attach
to both collagen Type I hydrogels and basement membrane MatrigelTM and
subsequently migrate and align to generate capillary-like network[53, 54].

Figure 2. 5 Examples of common proteoglycans and fibrous proteins. Source: [45]

2.3 Biopolymers
Typically, biomaterials can be classified into three groups: ceramics, metals,
and biopolymers[55]. Ceramic and metal scaffolds are predominantly used in
orthopedic applications and thus will not be covered in this dissertation. However,
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biopolymers have been implemented extensively as microvascular scaffold
materials due to their excellent biocompatibility, biodegradability, and ease of
processing characteristics. Based on the chemical structure and origin,
biopolymers can be further divided into three groups: (1) Natural biopolymers, (2)
Synthetic biopolymers, and (3) Composites. When considering which type of
biopolymer to use, there are several chemical and physical properties that must
be considered, beyond the typical biocompatibility and toxicity of the material, such
as the material’s mechanical properties, biodegradability, and processability
(Table 2.3 ), in addition to its ability to promote cell adherence and proliferation.
Table 2. 3 Properties of common natural and synthetic biopolymers. Source: [5659]
Hydrolytically

Polymers

Glass

Melting

Transition

Point

Tg (̊C)

Tm (̊C)

Tensile

Elongation

Elastic

Strength

at break

Modulus

(MPa)

(%)

Degradation
Time
(GPa)
(Months)

Natural
Collagen

40

70

202-224

37-39

0.002-0.2

-

Gelatin

50-70

25-85

0.66

62.5

0.002-0.03

-

Silk

178

192-203

16-20

5.29-5.79

1.5-14.8

-

Alginate

3-113

>300

31-37

11-17

-

-

Chitosan

156-170

99-131

82-166

5-8

0.002-0.007

-
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Synthetic

a

PGA

35-40

225-230

60-99.7

1.5-20

6-7

6-12

PLLA

40-70

130-180

15 -150

3-10

2.7-4.14

24-60

PDLLA

55-60

-

27.6-50

2-10

1-3.45

~ 12

PLGA

45-55

-

41-55.2

2-10

1-4.34

1-6

PCL

-65-60

58-63

20.7-40

300-1000

0.21-0.44

>24

PGA, poly(glycolic acid); PLLA, poly(L-lactic acid); PDLLA, Poly(D-lactic acid); PLGA,

poly(lactic-co-glycolic acid); PCL, Poly(ε-caprolactone).

2.3.1 Natural Biopolymers
Natural biopolymers are usually produced from plants or animals, and can
even be derived from microbial systems. Natural biopolymers have inherent
bioactivity present such as receptor binding ligands for cells. For example, Fittkau
et al. demonstrated the ability of biomimetic peptides, such as RGD, to selectively
affect adhesion and migration of human microvascular endothelial cells on
polyethylene glycol (PEG) surfaces[60]. In addition, materials from naturally
derived origins increase the potential for the biopolymers to have similar chemical
and/or physical characteristics as ECM components, which, in turn, may not induce
a chronic inflammatory or immunological response or be toxic to the cells, which is
often found in synthetic biopolymers[61]. Natural biopolymers can be recognized
by the biological environment and channeled into metabolic degradation by
undergoing enzymatic degradation through cleavage of the enzyme-sensitive
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bonds, and eventually lead to erosion of the biopolymer[62]. In specific applications
using a sacrificial scaffold, the degradation rate of the natural biopolymers can be
accelerated by increasing the concentration of the enzymes[63]. Conversely, the
degradation rate can be reduced by cross-linking[64] the biopolymer in order to
avoid rapid degradation of the scaffold which could lead to the collapse of the
developing microvascular network. Notwithstanding, natural biopolymers also
present some disadvantages, such as slow processing and inherent batch-tobatch variations[65].
Natural biopolymers can be divided into four groups: (1) Polysaccharides;
(2) Proteins; (3) Nucleic Acids; and, (4) Viruses (Figure 2.6) [66]. Nucleic Acids
and viruses are rarely used in microvascular scaffold applications. However,
proteins such as collagen, fibrin and silk fibroin, and polysaccharides such as
chitosan and alginate are commonly used in vascular/microvascular development
applications.

Figure 2. 6 Classification of several common natural biopolymers
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2.3.1.1 Collagen/Gelatin
As it has been introduced in the previous ECM section, collagen is the most
abundant protein in mammals, and it is the major component of connective tissues,
skin, bone, cartilage, and tendons. On the other hand, gelatin is a
biomacromolecule derived through the partial hydrolysis of collagen, which
converts the triple-helix structure into a coil structure due to cleavage of the
hydrogen and covalent bonds (Figure 2.7). As a result, gelatin has similar
biocompatibility and biodegradability characteristics to collagen, but collagen is
water soluble.
Collagen and gelatin have both been extensively used in tissue engineering
because of their biocompatibility, weak antigenicity, high mechanical strength, and
tunable biodegradability by controlling the degree of cross-linking[67]. Collagen
and gelatin are commonly used as hydrogels in tissue engineering[68, 69]. They
can also be processed into a variety of forms such as fleeces, sheets, tubes, fibers,
powders, and injectable solutions[70]. Moreover, these two kinds of protein are
popular natural biopolymers that are widely used to produce fibrous meshes and
scaffolds using electrospinning techniques [71-73].
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Figure 2. 7 Collagen triple helical molecules structure and gelatin coil structure.
Source: [74]

2.3.1.2 Silk fibroin
Silk fibroin is a natural protein commonly produced by arthropods such as
silkworms and spiders[86]. It exhibits a unique and useful combination of
properties such as good biocompatibility, non-inflammatory, excellent mechanical
strength, and low degradation rate. The silk fibroin molecule structure mainly
consists of glycine, alanine, and serine. In general, scaffolds made from silk fibroin
exhibit lower cell infiltration compared to other biopolymers. As a result, a number
of techniques have been employed to improve cell attachment to the scaffold
surface, including plasma treatment, cross-linking of the cell-binding domain, and
even genetic engineering approaches [58]. Silk fibroin has been processed into
films, nanofibers, membranes, mats, nets, hydrogels, and porous sponges using a
variety of methods such as wet spinning, electrospinning, and microfluidic
spinning[70, 87-89].
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2.3.1.3 Chitin/Chitosan
Chitin commonly comes from the exoskeleton of arthropods and insects or
the cell walls of fungi. Chitosan is a deacetylated derivative of chitin and a
polysaccharide. Although they are both semi-crystalline biopolymers with good
biocompatibility and biodegradability, chitosan attracts more attention because it
is soluble in aqueous acidic media. Chitosan can easily interact with adhesion
proteins, growth factors and other proteins since it has a linear monomeric
bond[75]. The degradation of chitosan depends on its molecular weight, the degree
of deacetylation, and the residual amount of acetyl content. Chemical modification,
such as cross-linking, can be easily performed due to chitosan containing hydroxyl
and amino moiety functional groups[76]. Wet spinning, electrospinning,
microfluidic spinning, and solvent casting have been reported as processing
techniques for fabricating chitin/chitosan into gels, films, particles, membranes,
fibers, and scaffolds for a large number of different applications[77-80].
2.3.1.4 Alginate
In addition to chitosan, alginate is another extensively studied natural
polysaccharide that is typically extracted from brown algae (Phaeophyceae) by
aqueous alkali solution treatment. Alginate is composed of guluronic acid (GBlocks) and mannuronic acid (M-Blocks)[81]. Different sources and production
processes usually yield different lengths and sequential distribution of these blocks;
thereby, directly affecting the molecular weight of alginate. The molecular weight
can influence the degradation rate and mechanical properties of alginate-based
biopolymers, for example, higher molecular weight alginate has a slower
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degradation rate[82]. As a U.S. Food Drug Administration (FDA) approved polymer,
alginate has many applications in the field of biomedicine due to its excellent
biocompatibility, biodegradability, and low production cost. Alginate is highly
suitable for hydrogels because it is hydrophilic, water-soluble and thickens in
neutral conditions. Alginate has been widely used to encapsulate various cells and
growth factors to fabricate cell-laden structures because it can be rapidly solidified
in calcium chloride (CaCl2) solution[83, 84]. In addition, alginate can be processed
into a fiber or fibrous structures by microfluidic spinning and other techniques [8589].

2.3.2 Synthetic Biopolymers
The first resorbable synthetic biopolymer commercially produced was
poly(glycolic acid) (PGA), which was developed by American Cyanamid Co. in
1962 and commercialized in 1970. Since that time, a number of other resorbable
synthetic biopolymers have been manufactured, including but not limited to
poly(lactic acid) (PLA), poly(lactide-co-glycolide) (PLGA), poly(caprolactone)
(PCL), etc. In synthetic biopolymer design and manufacture, the material’s
properties such as mechanical properties, hydrophilicity, and even bioactivity can
be customized by either chemical methods, such cross-linking with functional
groups, or physical methods, such as copolymerization with specific monomeric
units. The degradation rate can also be tuned by adjusting the monomer’s
concentration for drug delivery and tissue engineering[90]. For example, poly
(Lactide-co-Glycolide) (PLGA) is well known for shorter degradation times at
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higher glycolic acid concentrations. Most of the synthetic biopolymers undergo
hydrolytic degradation since they are usually associated with hydrolytically labile
chemical bonds such as esters, orthoesters, anhydrides, carbonates, amides,
urethanes, ureas, etc.[91]. The hydrolysis has its own downside such as the
byproduct carbon dioxide, which can lower the local PH and result in cell and tissue
necrosis. Another disadvantage of some synthetic biopolymers is they can be
biologically inert and may not promote cell adhesion and proliferation when used
as a scaffold. The cellular interaction with synthetic biopolymer scaffolds have
been shown to be improved by both physical and chemical methods, including
plasma treatment, covalent tethering of functional groups and augmentation with
bioactive molecules, such as gelatin and fibronectin[92, 93].
Synthetic biopolymers can be roughly divided into aliphatic polyesters,
poly(amino acids), polycarbonates, and others based on their chemical structures
(Figure 2.8). Among them, aliphatic polyesters such as poly(lactic acid) (PLA),
poly (Lactide-co-Glycolide) (PLGA), and poly(ε-caprolactone) (PCL) have been
extensively investigated for vascular/microvascular applications.

Figure 2. 8 Classification of several common synthetic biopolymers
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2.3.2.1 Poly(lactic acid)
Poly(lactic acid) (PLA) is a hydrophobic thermoplastic polymer. The
monomer lactic acid can be derived from an abundant number of natural,
renewable feedstock such as starch, wood chips or sugarcane[94]. Lactic acid has
two stereoisomerism forms: L-Lactide and D-Lactide. The polymerization of these
monomers leads to three morphologically distinct polymers namely, poly(L-PLA)
(PLLA), poly(D-PLA) (PDLA), and poly(D,L-PLA) (PDLLA). PLLA and PDLA are
semi-crystalline polymers while PDLLA is amorphous due to the random
distribution of L-and D-lactide units. Both the crystallinity and mechanical
properties of PLA can be tuned based on its molecular weight and the
stereochemical makeup of its backbone[95]. High molecular weight PLA is usually
prepared by the ring-opening polymerization method[96]. PLA undergoes
hydrolytic degradation by the bulk erosion mechanism with the random scission of
the main backbone and is more hydrophobic and the degradation time is long (15 years). In addition, the degradation byproduct lactic acid will also be broken down
into water and carbon dioxide via the citric acid cycle[97]. PLA is widely used in
many biomedical applications such as drug delivery or scaffolds for the
regeneration of cardiac, nerve, and bone tissue as well as blood vessels[98-100].
In the case of fiber formation, PLA fibers have been fabricated via wet spinning,
electrospinning, microfluidic spinning, melt spinning, and direct writing methods
[101-103].
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2.3.2.2 Poly(Lactide-co-Glycolide)
Poly(Lactide-co-Glycolide) (PLGA) was developed as a family of
copolymers with different lactide and glycolide compositions. PLGA is also
synthesized by means of a ring-opening co-polymerization of two different
monomers, glycolic acid, and lactic acid, and both

L-

and

DL-

lactides have been

used for the copolymerization process. Gilding et al. have shown that compositions
in the 25 to 75% range for Poly(L-Lactide-co-Glycolide) and 0 to 70% for the Poly(DLLactide-co-Glycolide) are amorphous[104]. PLGA has been shown to undergo bulk
erosion through hydrolysis of the ester bonds, and the degradation rates are
tunable by changing the ratio of PLA/PGA. Adding PGA into PLA will reduce the
crystallinity of the copolymers, and therefore increase the degradation rate due to
autocatalytic hydrolysis. For example,

50:50 Poly(DL-Lactide-co-Glycolide)

degrades in 1-2 months, 75:25 Poly(DL-Lactide-co-Glycolide) in 4-5 months and
85/15 Poly(DL-Lactide-co-Glycolide) in 5-6 months[105]. The degradation
byproduct of PLGA is poly(α-hydroxy acids), which can cause local acidosis in the
body[106]. PLGA has been approved by the Food and Drug Administration (FDA)
for fiber-based scaffold applications, and various fiber formation techniques have
been developed, such as direct writing, wet spinning, melt spinning, microfluidic
spinning [107-109], and especially electrospinning methods [110-113].
2.3.2.3 Poly(ε-caprolactone)
Poly(ε-caprolactone) (PCL) is a semi-crystalline synthetic polyester that is
prepared through a ring opening ε–caprolactone polymerization scheme[114]. PCL
has a low melting temperature (58 to 63 C
̊ ), and is solube in a wide range of
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organic solvents. PCL degrades slowly (>2 years) compared to other biopolymers
through the hydrolysis of its aliphatic ester linkages. The degradation rate can be
tailored by copolymerization with other lactones or glycolides/lactides. The good
biocompatibility, mechanical properties, and processability make PCL desirable for
tissue engineering applications, and more than 1500 papers have been published
in the last two decades describing PCL-based biopolymers being used in
biomedical engineering applications. In the case of fiber formation, PCL has been
extensively studied for use in 3D scaffolds for tissue engineering with micro/nanoscale fibers being achieved through several techniques including direct writing,
electrospinning, melt spinning, wet spinning and solvent casting [115-119].
Besides being used as single phase biopolymer, PCL is also a good base polymer
for developing co-polymers or composites[120, 121].

2.3.3 Composites
As mentioned in the previous section, each of these individual biomaterial
groups, including natural biopolymers and synthetic biopolymers, have their
specific advantages and disadvantages (Table 2.4). A biopolymer composite is
made by combining at least two constituent materials to produce a more viable
scaffold by taking advantage of each composed material, independently. Unlike
copolymers that are comprised of multiple different constituents, the phases of the
composite material remain separate, and they are mechanically separable in
theory, which allows for the transfer of loads between the different materials. The
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mechanical properties of composites can be tailored by carefully changing the
volume fractions of the constituent materials[122].
Table 2. 4 A general comparison of natural and synthetic biopolymers in the
scaffolding structure
Biopolymer

Advantages

Disadvantages

▪ Excellent biocompatibility, less
inflammatory or immunological

▪ Good cell attachment and signaling

biopolymer

batch variation
▪ May contain impurities or

reaction

Natural

▪ Slow production with batch-to-

heavy metal
▪ Mechanically weak

due to biologically active
▪ Controlled enzymatic degradation
with no harmful degradation

▪ Usually more expensive than
synthetic materials

product
▪ Usually highly porous and watersoluble, and easy to get hydrogel
▪ Good biocompatibility

Synthetic
biopolymer

▪ Biologically inert with poor cell

▪ Controlled hydrolytic degradation

attachment due to the lack of

▪ Predictable and tunable chemical

intrinsic surface ligands

and physical properties, generally
better mechanical performance
▪ Large-scale production with batch-

▪ May induce toxic degradation
products
▪ Mostly hydrophobic and not
water soluble

to-batch uniformity
▪ Lower cost with a long shelf life
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Extensive research has been performed in developing natural-natural,
synthetic-synthetic and natural-synthetic biopolymer composites for fiber or fibrous
scaffold fabrication. For example, several composite fibers or fibrous scaffolds
have been fabricated using fibrin and collagen[123], alginate and water-soluble
chitin [84], PLGA with collagen[124], PLGA with chitosan[125], PCL and
starch[126], and even silk fibroin, PLGA, and collagen[127]. As mentioned above,
one of the major advantages of generating composite materials is to tailor the
mechanical and/or chemical properties of the structure. Specifically, Slivka et al.
combined PGA and PLGA fibers to enhance the compressive modulus and yield
strength of articular cartilage scaffolds [128]. Similarly, Hokugo et al. produced a
fiber hybrid sponge, for guiding skin and cartilage tissue formation, consisting of
fibrin and PGA to yield a higher compressive modulus [129]. Another use of
composites is to increase the bioactivity of the synthetic biopolymer through the
introduction of natural biopolymers. Norouzi et al. demonstrated that hybrid
scaffolds for skin regeneration and wound dressing applications can be created
via co-electrospinning PLGA and gelatin improved fibroblast adhesion and
proliferation[130]. Besides the previously mentioned blend spinning techniques of
co-electrospinning and co-microfluidic spinning[131], another method to produce
a composite material is by spinning fibers directly onto an existing matrix. For
instance, Jeong et al. electrospun PLGA fibers onto the surface of tubular collagen
scaffolds for vascular graft construction to improve the mechanical strength of the
existing scaffold in both the dry and wet states[112].
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2.4 Fiber Fabrication Techniques
The utilization of biopolymers and the ability to controllably fabricate micronand nano-sized fibers only recently appeared over the last few decades, which has
opened the door for a wide variety of fiber-based tissue engineering approaches.
Recently, several fiber-based fabrication techniques have been implemented to
engineer 3D biomimetic tissue-like constructs with prescribed mechanical
properties, topography and composition[132].
For microvascular structure formation, there are two common strategies:
The first is to seed the cells in or on a fibrous scaffold and build a microvascular
structure in situ. The other approach is to seed the cells directly onto or into a
biodegradable fiber or fibrous scaffold that provides temporary mechanical support
and create the inner lumen by removing the sacrificial structure. Both approaches
are highly dependent on the fiber fabrication technique selected, which precisely
controls the structural, topographical, mechanical properties, and degradation
rates. In particular, the structural and topographical properties of the fibrous
scaffold have been found to be essential for cell distribution[133], and the
mechanical properties and degradation rate of the sacrificial fibers affect the
cellular interaction and lumen formation[134].
We will introduce several existing methods for fabricating fibers from natural
and synthetic biopolymers as well as composites while focusing on the current
and/or potential application in the creation of microvascular structures. These fiber
formation methods include (1) Electrospinning, (2) Microfluidic spinning, (3) Wet
spinning, (4) Melt spinning, (5) Direct write/solvent casting, and (6) Others.
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2.4.1 Electrospinning
Electrospinning is a fiber spinning technique driven by a high-voltage,
electrostatic field for drawing viscoelastic polymer fibers with diameters ranging
from a few nanometers to few micrometers[135-138]. A typical electrospinning
setup consists of a viscous polymer solution, a high voltage source (5-50 kV), a
pumping system with a spinneret (e.g. a pipette tip), and a grounded metallic
collector plate (e.g. metal screen, plate, or rotating mandrel) at an optimized
distance from the pipette tip based on the particular setup (Figure 2.9)[137]. In the
electrospinning process, the polymer solution is dispensed to the end of the
spinneret to form a droplet due to surface tension. The electrostatic force opposes
and eventually overcomes, the surface tension to eject a charged jet of the polymer
solution from the spinneret tip. The solvent evaporates from the solution when the
jet travels from the tip to the collector, eventually forming a continuous fibrous mat
on the collector[137]. The polymer solution properties (i.e., viscosity, surface
tension, and electrical conductivity), the flow rate, applied voltage and distance of
spinneret from collector directly affect the microstructure of the fibrous mat [139].
In addition, fibrous mats with random oriented or aligned fibers can be controlled
by changing a stationary collector to a rotating one[140].
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Figure 2. 9 Schematic diagram of set up of electrospinning [141].
Electrospinning is a versatile and relatively simple technique that can be
used to process many biopolymers into fibers. In fact, electrospinning is one of the
most commonly used scaffold fabrication techniques because it can easily produce
a nanofibrous mat with an ECM-like architecture. You et al. constructed
nanofibrous scaffolds from PGA, PLA, and PLGA and evaluated the
biodegradation rate of these scaffolds[140]. Fioretta et al. investigated the impact
of different fiber diameters (2, 5, 8, and 11 μm) in electrospun PCL scaffolds on
endothelial colony forming cells (ECFCs) in comparison to mature human umbilical
vein endothelial cells (HUVECs). The results suggested that the individual fiber
diameters of the fibrous scaffold can determine cell phenotype[115].
Some researchers have indicated that aligned electrospun ultrafine fibers
can regulate cellular alignment and relevant functional expression. Dalton et al.
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electrospun fibers with diameters of ~960 nm from blends of PEG and PCL and
patterned them into aligned lines and seeded with fibroblasts. The seeded
fibroblast morphology was observed to be affected by the fiber orientation[142].
Zhang et al. prepared hydrogel fibers with uniaxial alignment from aqueous
solutions of natural polymers such as alginate, fibrin, gelatin, and hyaluronic acid
using an electrospinning technique in combination with electrical and mechanical
stretching. The internal alignment feature enhanced the mechanical properties of
the hydrogel microfibers and induced HUVEC alignment[143]. The fiber
topography was also shown to affect cell behavior. Santos et al. electrospun PCL
nanofibrous meshes on fibronectin-coated PCL fibers (160 nm in diameters) for
endothelial cell migration in bone tissue and discovered that the ECs expressed a
more elongated phenotype when compared to the PCL fibers with no nanofiber
mesh[144]. Ekaputra et al. utilized a dual electrospinning /electro-spraying setup
to fabricate a scaffold containing PCL fibers, collagen, and a hyaluronic acid-based
hydrogel. This multi-component design encouraged osteoblasts to penetrate the
scaffold, rather than simply growing across its surface[145].
With respect to vascular constructs, Xu et al. used a rotating collector to
produce an aligned nanofibrous mat of poly(l-lactide-co-e-caprolactone) [P(LLACL)] (75:25) copolymer with the average diameter of the aligned fibers being 550
nm in order to create a scaffold for potential use as a blood vessel scaffold. Smooth
muscle cells (SMCs) were seeded onto the scaffold, and SMC cytoskeletal
proteins were found to align in the direction of the scaffold fibers[146]. Similarly,
Zhu et al. employed a mandrel collector to fabricate porous fiber meshes of
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macroscopically aligned PCL fibers with an average diameter of ~10 µm for
vascular tissue engineering applications. Human umbilical artery smooth muscle
cells and HUVECs were seeded and cultured on these scaffolds[147]. Zhou et al.
fabricated aligned PLLA microfibers with an average fiber diameter of 1.6 µm by
using a jet electrospinning method. Ellipse-shaped nano-pores were incorporated
in situ onto individual fiber surfaces to form nano-topographical features by varying
ambient humidity. A 7-day in vitro assessment of human vascular smooth muscle
cells (vSMCs) cultured on these fibers indicated correlations with the nanoroughness[102].
Recently, electrospun fiber-based scaffolds have been improved by
incorporating other components to obtain a bioactive coating or hybrid scaffold.
Kwon et al. co-electrospun poly(L-lactide-co-caprolactone) (PLCL) with type I
collagen and demonstrated that HUVECs exhibited improved attachment on the
scaffold relative to a collagen-free scaffold[148]. Jeong et al. co-cultured SMCs
and ECs onto a similar hybrid scaffold composed of a porous collagen matrix and
an electrospun fibrous PLGA layer for vascular graft applications [112]. Likewise,
Barreto-Ortiz et al. electrospun microfibers (average diameter ~200 µm) composed
of a fibrin-coated hydrogel mixed with alginate and demonstrated that these
microfibers could be used to guide the stepwise formation of multicellular
microvascular structures comprised of ECFCs, vSMCs, and pericytes[149].
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2.4.2 Microfluidic Spinning
Microfluidic spinning, also known as co-axial flow spinning, is a fiber
formation technique based on micro-fluid dynamics principles. A typical
microfluidic spinning system is comprised of a central channel, which delivers the
polymer solution (sample flow) into the main channel, and two side channels that
deliver sheath flow around the sample flow (Figure 2.10)[132, 150]. Due to the
laminar nature of the flow in the microfluidic channel, the interface between the
sheath flows and sample flow remains stable and polymerization only occurs
downstream by either UV light exposure, ionic or chemical crosslinking process or
a solvent exchange method[150]. The fiber diameter and cross-sectional shape
are tunable by changing the polymer solution viscosity, the ratio between the
sample flow and sheath flow rates and the channel geometry[151, 152]. Fibers
with aligned orientation can be achieved by utilizing a rotating roller collector[153].
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Figure 2. 10 Schematic diagram of set up of microfluidic spinning [150]. In this
process, fiber solidification can be achieved by either a solvent method or nonsolvent method, including photopolymerization, ionic crosslinking, solvent
exchanging and chemical crosslinking.

One major advantage to this technique is that the sample flow can be
loaded with cells, which can remain viable and functional because the microfluidic
channels are usually short in length and the cells are only exposed to a high shear
stress for a very short period of time. Despite numerous advantages offered by
microfluidic spinning, there are downsides to this technique. For example, the short
amount of time available to solidify the fibers limits the choice of materials. Until
now, only a handful of biopolymers have been used to produce microfibers through
this technique. In addition, the microchannel can easily clog, which significantly
affects yield. In addition, the microfluid spinning technique lacks the ability to
generate cylindrical shapes that are similar to in vivo environment.
Nonetheless, microfluidic spinning is emerging as a promising method for
producing continuous fibers from biopolymer solutions. Reviews on general tissue
engineering applications of this technique are available elsewhere[66, 133, 150,
154]. Additionally, several investigators have developed microfluidic spinning to
develop models for better understanding of neuronal and cancer growth, which
also have the potential for being used in the construction of microvascular
structures. Specifically, Kang et al. employed a PDMS microfluidic platform to
continuously generate alginate thin flat fibers (thickness < 10 µm) with engraved
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grooved patterns that were used to align different cells, such as cortical neuronal
cell and myoblast cells[87]. Similarly, Hwang et al. designed a PDMS-based
microfluidic spinning device to produce PLGA microfibers with diameters ranging
from 20 to 230 µm and demonstrated the ability to culture aligned L929 fibroblasts
[108]. Wei et al. produced microfluidic-based cell-laden microfibers from UV-crosslinkable methacrylated alginate and HUVECs and MG63 cells[155]. In another
study, a collagen suspension of Hep-G2 and HUVECs hydrogel microfibers were
processed into microfibers (diameter ~230µm) by Stato et al. via a double coreshell type microfluidic device and confirmed the connection of the cells by
cultivation[156].
For microvascular structure formation, Tung et al. fabricated microvascular
scaffold composed of PLGA fibers using a PDMS replica mold. These PLGA fibers
featured diameters ranging from 13-50 µm that were wrapped with HUVECs on
both sides[157]. Daniele et al. utilized poly(ethylene glycol) dimethacrylate
(PEGDMA) and gelatin to create a variety of microvascular structures, including
microfibers, microtubes, coaxial microfibers, and triaxial microfibers[131]. In a
more recent study, Tian et al. presented a gas-in water microfluidic method to
fabricate alginate-based composite microfibers with “cavity knots” and assembled
them into a 3D scaffold, in which HUVECs were cultured to create a vascular
structure[158]. Cell-laden fibers can also be produced by microfluidic spinning
technique. For example, Lee et al. used a microfluidic chip and a mixture of Human
Iliac Vein Endothelial-78 cells (HIVE-78) and 2 wt.% alginate solution to generate
hollow alginate cell-laden fibers. Then they embedded these cell-laden fibers into
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hydrogels with smooth muscle cells and successfully cocultured these cells for
seven days[159].

2.4.3. Wet Spinning
Wet spinning is a non-solvent-induced, phase-inversion, fiber fabrication
technique that can yield microfibers with a wide range of diameters[160]. A
standard wet spinning setup includes an injection system (can be driven manually,
gravitationally, or by a syringe pump), a reservoir for the polymeric solution, a
spinneret and a coagulation bath (which must contain either a poor solvent or nonsolvent for the polymers)(Figure 2.11)[132, 161, 162]. During spinning, the
polymeric solution is continuously injected into one or multiple coagulation baths
and the long continuous filament solidifies due to the polymer and solvent/nonsolvent exchange[161]. Some improved wet spinning systems introduce a fiber
collection component such as rotating mandrel to attain circumferentially oriented
microfiber scaffolds[163, 164].
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Figure 2. 11 Schematic diagram of set up of wet spinning [162]
While wet spinning is not able to produce scaffolds with ultra-small sized
fiber diameters, in general, like electrospinning and microfluidic spinning, the fiber
diameter is still similarly controlled by the polymer viscosity, the injection rate and
the spinneret size[165]. One advantage of wet spinning scaffolds is that they have
larger pore sizes compared to those fabricated by electrospinning, which is
favorable for cell adhesion and cellular penetration within the scaffold[116, 166].
Wet spinning can also incorporate of cells within the fibers just like microfluidic
spinning. However, the cross-linking reagents must be cell friendly because the
cell exposure time is much longer than microfluidic spinning.
Wet spinning is a straightforward and very easy to set up, and it has the
capability of high volume fiber production if multiple spinnerets are used. A variety
of natural biopolymers, synthetic biopolymer, and the composites thereof have
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been used to generate micron size fiber-based scaffolds[132, 133]. In the case of
microvascular structure applications, Zhang et al. developed a new wet spinning
system to fabricate oriented PCL microfiber scaffolds with the fiber diameter and
porosity being controlled in the range of 7-27 µm and 68 to 82%, respectively.
SMCs could grow in an oriented fashion along the fibers and infiltrate inside the
scaffold[116]. Takei et al. extruded sodium alginate solution containing bovine
carotid artery vascular endothelial cells (BECs) into CaCl2 solution and obtained
microfibers. The BECs eventually migrated into the ambient collagen gel and selfassembled into capillary-like structures[88]. Microvascular networks could also be
created by wet spinning sacrificial microfibers. In a recent study, Lee et al. reported
a sacrificial template-based strategy utilizing wet spun poly(N-isopropylacrylamide)
(PNIPAM) fibers (diameters ranging from 3-55 µm) to produce 3D microvascular
networks in cell-laden gelatin hydrogels. This capillary-like microvascular network
allowed constant perfusion of the media and improved the viability of human
neonatal dermal fibroblasts encapsulated within the gel[167].

2.4.4 Melt Spinning
Melt spinning, sometimes called extrusion, is widely used for fiber formation
in the polymer industry. In the standard process of melt spinning, a polymer is
heated to its melting point and extruded through a micron-sized spinneret orifice
and then directly solidified into continuous fibers by rapid cooling (Figure 2.12)
[133]. In general, melt spinning tends to produce the largest diameter fibers (on
the order of a few hundred microns) compared to the previously mentioned fiber
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fabrication techniques. However, melt spun fibers with a diameter under 100 µm
have also been reported[168]. The fibers’ diameter is affected by the polymer’s
characteristic properties, size of the spinneret orifice, spinning temperature, and
extrusion rate[169]. Melt spinning has a unique advantage in its ability to create
controlled, complex cross-sections of the fibers. Star shape, fractal-like, grooved
and even hollow fibers have been produced by melt spinning with special designed
spinneret orifices [170-173]. Researchers have shown fibers with grooved crosssections assist in cells attaching and aligning themselves parallel to the direction
of the grooves[171]. Associated results also support that the mechanical properties
such as tensile strength and Young’s modulus are improved by melt spinning[101].
However, due to the spinning process requiring high temperatures, it is challenging
to incorporate cells into the melt spinning fiber process like microfluidic spinning
and wet spinning.

Figure 2. 12 Schematic diagram of set up of melt spinning [133]
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Melt spinning was first used to produce fibers in the textile industry and now
it is an appeal in the creation of biopolymer fibers has grown recently in the tissue
engineering arena. Park et al. utilized three customized spinnerets to produce PCL
fibers with circular, triangular, and cruciform cross-section and the equivalent
diameters of ~200 µm. They further showed the woven scaffolds composed of the
fibers with noncircular cross-section significantly increased the proliferation of
human osteosarcoma MG63 cells and decreased the degradation time[117]. Wu
et al. assembled melt spun PGA-PLLA fibers into a non-woven scaffold and
showed that human endothelial progenitor cells (EPC) have an inherent ability to
assemble into a microvascular-like network[174]. Similarly, melt spun fibers were
used as sacrificial fibers to create 3D microvascular networks. Specifically, Bellan
et al. used cotton candy to fabricate sugar fibers and then developed a 3D
perfusable microvascular network using the sugar fibers as sacrificial
structures[134]. In a more recent study, Patrick et al. developed a 3D
interconnected microvasculature in which the sacrificial fiber composed of PLA and
tin(II) oxalate was melt spun with diameters of the composites fibers ranging from
550 to 850 µm[175].

2.4.5 Direct Write/Solvent Casting
Traditional solvent casting is a fiber manufacturing process that involves
mixing of a solubilized polymer matrix and filler under continuous agitation through
mechanical stirring, followed by casting and solvent evaporation or drying
steps[176]. In this straightforward process, the polymer is first dissolved in an
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appropriate volatile solvent or water, and then the polymer solution is cast on a
substrate such as a flat surface or heated drum. The traditional process does not
need special equipment and is very easy to implement, and thus, has become
popular for biological applications. For example, Lieder et al. developed a protocol
for solvent casting chitosan membranes and demonstrated that the mouse preosteoblastic cell line MC3T3-E1 could be successfully attached for 24 days[78].
Overall, the solvent casting method is an inherently slow process, but the
concept itself offers potential when adapted to micro- and nano-scale applications
using specialized equipment. Specifically, a technique known as direct write was
recently developed to create a fiber-based scaffold for tissue engineering and
microvascular network applications[177, 178]. A typical direct write setup includes
a computer-controlled translation stage, a deposition nozzle, and a deposition
substrate (Figure 2.13). Nain et al. and Berry et al. have produced polymer fibers
with micro- and nanoscale diameters by directly ejecting polymer solution from a
hollow capillary and then thinning into filaments by capitalizing on the surface
tension-driven necking phenomenon, which like solvent casting leverages the
solvent volatility to form fibers [179, 180]. Berry et al. further showed that the fiber
diameter could be controlled by solution concentration, drawing rate, and fiber
length[181]. They also demonstrated the ability to generate micron-sized fibers
from a variety of biopolymers such as PCL, PLLA, PDLLA, and

DL-PLGA[181].

Similarly, Vozzi et al. have utilized a pressure assisted micro-syringe to direct write
PLGA scaffolds with feature sizes of 10-30µm[111]. Guo et al. have reported a
robotic system to print various geometries such as filaments, towers, and freeform
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circular spirals from PLA[182, 183]. In another study, Kullenberg et al. have
employed a pressure-assisted micro-syringe (PAM) system to fabricate hexagonal
scaffolds of PLGA fibers and discovered the optimized hexagonal scaffold size for
neural cell adhesion[184]. Nain et al. have developed a Spinneret-Based Tunable
Engineered Parameters (STEP) technique to construct aligned microfibers using
both PLA and PLGA. They further investigated the effect of the scaffold
morphology to the mouse C2C12 cellular behavior[185]. Similarly, Wang et al.
fabricated suspended multilayer hierarchical nanofiber scaffold using STEP
technique and seeded C2C12 mouse myoblasts on the scaffold[186].

Figure 2. 13 Schematic diagram of set up of direct write
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The direct write technique offers more dimensional and textural control
compared to other fiber spinning techniques. More recently, Berry et al. created
microvascular scaffolds using the direct write technique and successfully seeded
the fibers with HUVECs. These scaffolds were created as either individual fiber
strands or with branched structures composed of suspended synthetic biopolymer
(L-PLA, DL-PLA, PLGA (50:50 and 75:25) and PCL) microfibers with microvascularscale diameters (5-20 µm) and point-to-point orientation[118]. Direct write
technique can also incorporate cells within the fibers and produce cell-laden fibers
for microvascular structures. Gaetani et al. have used a bioprinting system and a
mixture of HUVECs and alginate to form an endothelialized micro-fibrous
scaffold[89].

2.4.6 Others
In addition to the five previously mentioned fiber fabrication techniques,
some other polymer fiber-based scaffold methodologies have been implemented
to produce cellular scaffolds. Although these scaffolds are not all used for creating
microvascular structures, these methodologies still hold promise for future
applications. For example, Interfacial Polyelectrolyte Complexation(IPC) is a
process whereby fibers and capsules are formed through interactions at the
interface of oppositely charged polymers[187]. One significant advantage of the
IPC process is the ability to encapsulate biological components such as cells,
extracellular matrix proteins, growth factors, and plasmid DNA. Du et al. have
developed a method to draw IPC fibers and encapsulate hepatic and endothelial
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cells into the fibers to assemble endothelialized liver tissue constructs[188].
Human mesenchymal stem cells (hMSCs) encapsulated in IPC fibers made from
alginate and water-soluble chitin polymers have been reported by Yim et al.[84].
Similarly, Lu et al. used a microfiber system to fabricate IPC fibers for human
pluripotent stem cell (hPSC) encapsulation[189]. More recently, Lim et al. used the
same polymers to generate 3D fibrous hydrogel cell-laden scaffolds for engineered
follicular structures[190]. In general, the IPC technique requires a relatively simple
setup; however, both the biopolymer selection available for this process and the
working fiber diameter range is limited.
Rotary Jet Spinning(RJS) is another reproducible technique for bulk nano/micro-fiber production. In this process, the polymer solution is ejected from the
micron-sized orifice in a high-speed rotating reservoir, and nanoscale polymer
fibers are solidified on the collector by solvent evaporation. Golecki et al. have
fabricated PLA nanofibers with a diameter ranging from ~250 to 950 nm and
revealed that fiber drying played an important role in determining nanofiber
morphology[191]. In another study, Badrossamay et al. utilized PLA/chloroform
solution to fabricated aligned 3D nanofiber structures with diameters ranging from
50 to 3500 nm, and they further created anisotropic muscle with aligned and
elongated myocytes and ordered myofibrils, based on the nanofibers[192].
A variety of rarely utilized fiber formation techniques have also been
reported

for

tissue

engineering

applications.

Qiu

et

al.

found

that

polyvinylpyrrolidone (PVP) could self-assemble into branched hollow fibers, which
can potentially be applied to forming artificial blood vessels[193]. Wang et al. used
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femtosecond laser ablation to fabricate pillared PLGA microvessels and observed
that bovine endothelial cells adhered well and grew to surround each branch of the
pillared microvessel network[194]. In recent research, Kalisky et al. have
presented a method to produce microfibers (~50 µm) using a core-shell approach,
composed of a calcium alginate shell and a cellularized type I collagen core. This
approach can control fiber diameter and geometry, and it also allows cultured cells
to distribute preferentially on the surface of the fiber and display a uniform cellular
orientation[83].
A comparison of the biopolymer fabrication techniques is shown in Table
2.5. The Summary of recent studies on microvascular structures using the different
fiber fabrication techniques and cell types is shown in Table 2.6.
Table 2. 5 Comparison of different biopolymer fabrication techniques
Fiber
fabrication

Advantages

Disadvantages

technique
▪ Multiple biopolymer choices

▪ Not

suitable

for

cell

▪ Ability to form nano-scale fibers

encapsulation due to harsh

▪ Volume production

process
▪ Difficult to fabricate single fiber

Electrospinning

or spatially controlled structure
▪ Difficult to form a thick 3D
structure
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▪ Ability to control fiber crosssectional shape and diameter
Microfluidic
spinning

▪ Tiny

volume

sample

▪ Complicated setup
▪ Limited biopolymer choices
▪ Microchannel clogging

consumption
▪ Suitable for cell encapsulation
▪ Ability to get hollow or coaxial
fibers
▪ Pre-controlled fiber diameter

Wet spinning

▪ Suitable for cell encapsulation

▪ Unable to form nano-scale
fibers
▪ Difficult to get aligned fibers

▪ Ability to control fiber crosssectional shape and diameter

▪ Not

suitable

encapsulation

for
due

to

cell
high

Melt spinning
▪ Simple setup

temperature
▪ Limited to large fiber diameters

▪ Ease of fabrication without the
need for specialized equipment
Solvent casting

▪ Limited biopolymer choices
▪ Unable

to

control

fiber

alignment
▪ Slow process
▪ Limited to large fiber diameters
▪ Ability

to

control

fiber

orientation and diameter

▪ Complicated

setup

(i.e.

computer-controlled translation

Direct write
▪ Ability to form nano-scale fibers
▪ Suitable for cell encapsulation
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stage)
▪ Difficult for volume production

Interfacial
polyelectrolyte

▪ Suitable for cell encapsulation

▪ Limited biopolymer choices

▪ Ability to get hollow or coaxial

▪ Unable to control the fiber
alignment

fibers

complexation

Table 2. 6 Summary of recent studies on microvascular structures using the
different fiber fabrication techniques and cell types
Fiber
Fiber
Fabrication

Biopolymers

Cell Type

Ref.

Diameter
Technique
PCL

2-11 µm

ECFCs, HUVECs

[115]

550 nm

SMCs

[146]

PCL

10 µm

SMCs and HUVECs

[147]

PEG and PCL

960 nm

Fibroblasts

[142]

HUVECs

[143]

vSMCs

[102]

PCL-PLA
copolymer

Electrospinning

Alginate, fibrin,
gelatin, and

10-25 µm

hyaluronic acid
PLLA

1.6 µm
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PLCL and
120-520 nm

HUVECs

[148]

Submicron

SMCs and ECs

[112]

collagen
PLGA
Fibrin hydrogel
ECFCs, vSMCs,
mixed with

200 µm

[149]
and pericytes

alginate
PCL

160 nm

HUVECs

[144]

PCL

1-2 µm

Osteoblasts

[145]

PLGA

~ 10 µm

HUVECs

[195]

PLGA

20-230 µm

L929 fibroblast

[108]

Cortical neuronal
Alginate

< 10 µm

cell and myoblast

[87]

cells
Chitosan

50-200 µm

Fibroblast

[80]

Calciµm alginate

19 µm

Fibroblast

[85]

Calciµm alginate

40-300 µm

Microfluidic
spinning
HepG2 and NIH
[86]
3T3
PLGA

13-50 µm

HUVECs

[157]

< 500 µm

-

[131]

PEGDMA and
gelatin
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Alginate-based
composite

~100 µm

HUVECs

[158]

HIVE-78， SMCs

[159]

solution
Alginate

40-220 µm

Alginate

~450 µm

HUVECs and MG63
[155]
cells
Collagen

~230 µm

HUVECs

[156]

PCL

7-27 µm

SMCs

[116]

250-500 µm

BECs

[88]

Sodiµm alginate
Wet spinning

Fibroblasts and
PCL

150 µm

[119]
myoblasts

PNIPAM

3-55 µm

Fibroblasts

[167]

PCL

~200 µm

MG63 cells

[117]

EPC

[174]

PGA-PLLA

Melt spinning

-

Collagen

200-300 µm

-

[70]

Chitosan

286-352 µm

VICs

[79]

20 µm

-

[134]

550-850 µm

-

[175]

Cotton sugar
PLA and tin(II)
oxalate
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Pre-osteoblastic
Chitosan

-

cell line MC3T3-

[78]

E1
PMMA, PCL,
PLLA, PDLLA,

1-100 µm

-

[181]

10-30 µm

-

[111]

80 µm

-

[182]

SH-SY5Y cell line

[184]

and PLGA
PLGA
PLA
PLGA

Solvent casting

10-30 µm

C2C12 mouse cell
PLA and PLGA

50 to 500 nm

[185]
line

100 nm to

C2C12 mouse

Polystyrene

[186]
micrometers

myoblasts

5-20 µm

HUVECs

PCL, PLLA,
[118]

PDLLA and PLGA
Human cardiacderived
Alginate

-

[89]
cardiomyocyte
progenitor cells

Fibrin

93 µm
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HMVECs

[32]

Water-soluble

Hepatic cells and
-

chitin

[188]
endothelial cells

Alginate and
water-soluble

10 µm

hMSCs

[84]

chitin polymers
Water-soluble

Human embryonic
~200 µm

chitin

[189]
stem cells

Alginate and
Human follicle DP
-

water-soluble

[190]
cells

Others

chitin polymers
~250 to 950
PLA

-

[191]

Myocytes

[192]

-

[193]

BECs

[194]

nm
50 to 3500
PLA
nm
PVP
PLGA

~5 μm
47 to 80 μm

Mouse bone
Calcium alginate
~50 µm

marrow stromal

and collagen
precursor cell line

54

[83]

CHAPTER 3: MATERIALS AND METHODS
3.1 Overview
In this chapter, the instrumentation and techniques used to fabricate
precisely positioned, three-dimensional, suspended branched microvascular fiber
scaffolds and form a confluent monolayer of Human Dermal Microvascular
Endothelial Cells (HDMECs) on the scaffold are described.
The schematic illustrating the formation of a microvascular network is
shown in Figure 3.1. The fabrication process consisted of implementing a 3-Axis
robotic dispensing system for creating a suspended, branched micro-fiber scaffold
(Figure 3.1A). The direct-write system was able to predictably and repeatedly
construct micro-fibers with microvascular-scale diameters (5 – 20 µm). An
empirical model was generated based on the gelatin fiber characterization data to
express micro-fiber diameter in terms of the direct-write system operational
parameters and polymer solution properties. The empirical model was validated
and tested by drawing fibers from various biopolymers, composites, and
copolymers. Upon completion of the fabrication process, HDMECs were seeded
on the scaffold and cultured for two days. The cells wrapped circumferentially
around the scaffold and spread along the axial direction of the scaffold (Figure
3.1B-C). The HDMECs-covered scaffold was subsequently cultured in a labderived extracellular matrix (ECM) for an additional three days. The ultimate vision

55

is that the cells can attach to the ECM and maintain the lumen shape after the
scaffold is degraded (Figure 3.1D).

Figure 3. 1 Schematic illustrating of the concept of the formation of a microvascular
network, and the cross-sectional images are inserted. A) Direct-write branched
structure scaffold, B) seeded HDMECs on the surface of the scaffold in the media,
C) HDMECs grew along the axis and around the circumference of the scaffold in
the media, and D) vascularized-sheet with HDMECs-scaffold embedded in the
ECM
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3.2 Instrumentation and Equipment
3.2.1 3-Axis Robotic Dispensing System
The biopolymer micro-fibers were direct-written from an integrated 3-Axis
robotic dispensing system (Nordson Corporation, Westlake, OH; Figure 3.2A-B).
This system is composed by the following subsystems: (1) JR 2203N 3-Axis
Desktop Robot with accessory JR C-Points software (Janome Sewing Machine
Co., Tokyo, Japan). The X-Y-Z robot axis has an operational range of 200 by 200
by 50 millimeters, respectively, with a positioning resolution of 0.005 mm for X- and
Y- Axes and 0.0025 mm for the Z-Axis. The X- and Y- Axes can be operated from
7 to 500 mm/second, and the Z-Axis can be operated from 2.5 to 250 mm/second;
(2) Valvemate 7100 Dispensing Valve Controller (Nordson Corporation, Westlake,
OH). It can adjust the valve open time from 0.001 to 99.9 seconds with 0.001
second increment by programming; (3) EFD-741 MD Series MicroDot Dispense
Valve (Nordson Corporation, Westlake, OH); (4) EFD Optimum Dispensing Tips
(Nordson Corporation, Westlake, OH), the inner diameters are coded by hub colors
(Red: 0.25 mm, Clear: 0.20 mm, Lavender: 0.15 mm, Yellow: 0.10 mm) (Figure
3.2C); (5) USB Digital Microscope Camera (Microview, Guangzhou, China). (6)
2F500-1W Feedback control heater (Cadet, Vancouver, WA); and (7) Customized
Polycarbonate Thermal Enclosure. The heater and enclosure can be used to
maintain a constant temperature and consistent solvent evaporation rate.
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Figure 3. 2 Optical Images of 3-Axis robotic dispensing systems: A) Image of 3Axis robotic dispensing system housed inside an enclosure; B) Close up image of
the dispensing valve with attached USB microscope for visualization; C) Image of
EFD Optimum Dispensing Tips with four colors indicating four different inner
diameters.
3.2.1.1 Operation
Turn on the computer, desk robot, and valve controller and adjust the air
pressure to 15 psi. Launch the JR C-Points software to initialize the X-Y-Z Axes
stage and then firmly mount the designed substrate on the X-Axis stage. The
microscope camera was activated and focused on the needle, and the dispensing
tip was manually positioned to the predefined initiation spot and while the Z-height
was adjusted to find the optimum initial distance above the substrate by using
“JOG” function (Figure 3.3A). Process parameters such as the initiation and
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termination X-Y coordinates of the fiber, dispensing tip lift height, dispensing tip
travel velocity (feed rate), and dispense time were input into the JR C-Points
software (Figure 3.3B) and then uploaded into the memory of 3-Axis robotic
dispensing system by clicking “Sent C&T Data” button (Figure 3.3C) The Valve
open time was manually input into the valve controller. After 3 mL of biopolymer
solution is loaded into the pressurized barrel and purged to eliminate the trapped
air, click the “Test Run” button (Figure 3.3C) to execute the automatic drawing
process.

Figure 3. 3 Graphic interface of JR C-Points software
3.2.1.2 Cleaning and maintenance
Leaving the polymer in the dispense valve overnight may cause congestion,
thus a proper cleaning and maintenance process at the end of the day or before
changing different polymer solutions is critical. The pressurized barrel and
dispensing tips can be simply discarded. To thoroughly clean the polymer solution,
the EFD-741 Dispense Valve was carefully disassembled into components by
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following the manufacturer’s guidance (Figure 3.4). Firstly, all components were
washed by running hot water (70 ̊C) through the components to remove large
polymer solution residue. Then all parts except the rubber O-ring were immersed
into a beaker of acetone and subjected to an ultrasonic bath for 30 minutes.
Subsequently, deionized (DI) water was used to rinse all the parts and the parts
were then dried by compressed air. Needle packing assembly and piston/needle
assembly needed to be lubricated with Nye Lubricant #865 gel before being
reinstalled.

Figure 3. 4 Image of disassembling components of EFD 741 dispense valve

3.2.2 Rheometer
The viscosity of the biopolymer solutions was measured by rheometer
(Physica MCR 300, Anton Paar, Austria; Figure 3.5). The principle of this
rheometer is similar to a standard cone and plate viscometer, which applies shear
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on a fluid between the rotating cone and the static plateto measure the rotational
resistance exerted by the fluid. The viscosity is calculated by the software from the
resistance torque. This rheometer can determine a viscosity curve over a broad
range of shear rates. A column-shaped heated/refrigerated water bath and
circulator was attached and employed to maintain the test temperature.

Figure 3. 5 Image of Physica MCR 300 rheometer under testing
Turn on the water bath and warm up the rheometer for least 15 minutes.
Next, remove the cone and plate (the choosing cone is DG 26.7 with a diameter
= 1 mm and plate is TEZ 150P-C) from the protect box and add 10 mL biopolymer
solution into the plate. Then, properly mount the cone and plate to the position.
Launch the Physica RheoPlus software and input the sample name, test
temperature (25 ̊C), cone and plate code, shear rate range (0.1 – 1000 1/s) and
time interval (150 s). By clicking the “Start” button, the machine will automatically
operate by first heating to the desired temperature and then increasing the cone
rotation speed until it reached the maximum rotational resistance was reached.
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The viscosity curve over different shear rate was plotted and saved to the computer.
The rheometer was calibrated by the calibration standard fluid 5000 every month
(Viscosity = 4930 mPa*s at 25 C
̊ , Brookfield, Middleboro, MA; Figure 3.6).

Figure 3. 6 The viscosity of standard fluid for calibration

3.2.3 Du Nüoy-Paddy Surface Tension Measurement System
The surface tension of the biopolymer solutions was measured by using the
Du Nüoy-Paddy method. This method involves slowly lifting a rod from the surface
of the solution. The force required to raise the rod from the solution’s surface is
measured and related to the solution’s surface tension. The custom surface
tension measurement system is shown in Figure 3.7. A glass rod (diameter = 3.2
mm) was vertically attached to a linear actuator (Firgelli L12) which was fixed to
height adjusted stand. A precise balance (Mettler, PM100) was positioned to make
sure the glass rod is vertical to the center of the balance weighing platform. A
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LabView VI was programmed to control the linear actuator expense and contract
through an Arduino microcontroller (UNO). Two USB- cameras were also used to
monitor and record the balance reading and the interface between the glass rod
and the solution surface.

Figure 3. 7 Image of custom Du Nüoy-Paddy surface tension measurement system.
Inserted images showed the instant images of the balance reading and the
interface between the glass rod and the surface of the solution
A calibration was performed to make sure the LabView program and the
Arduino microcontroller can control the linear actuator to expand and contract
smoothly and accurately (Figure 3.8). 0.5 mL biopolymer solution was loaded into
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a small glass sample bottle and positioned on the center of the balance weighting
platform. The glass rod was dipped into biopolymer solution a few millimeters
under the surface and the balance reading (M1) was recorded. The LabView
program was employed to contract the linear actuator and record the balance
reading (M2) when the glass rod was detached from the solution. The force (F)
exerted on the rod due to the surface tension was calculated by:
𝐹 = (𝑀1 − 𝑀2 ) ∗ 𝑔

(3-1)

The surface tension, σ, could be calculated by:

𝜎=

𝐹
𝑝∗cos(𝜃)

(3-2)

Where the p is the perimeter of the rod (p = 10.1 mm according to d = 3.2 mm), θ
is the contact angle of the solution on the rod. The glass rod was chosen since all
tested solutions were found to wet glass completely such that θ approached 0 .̊
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Figure 3. 8 Calibration of the linear actuator length corresponding the LabView
Control position input

3.2.4 Thermogravimetric Analyzer (TGA)
Mass transfer coefficients of polymer solutions were measured by a
thermogravimetric analyzer (SDT Q600 Simultaneous TGA/DSC, TA Instruments,
New Castle, DE; Figure 3.9). The device can be used to measure high-precision
weight change in the isothermal environment.

Figure 3. 9 Image of TA SDT Q600 Simultaneous TGA/DSC. Inserted image
shows the ceramic cup that holds the sample
Turn on the machine and warm it up for 30 minutes. ~30 mg biopolymer
solution was loaded into a ceramic cup after taring the empty cup. Launch the
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QSeires software (Figure 3.10) and change the gas source to air. Set up the
running sequences as below: (1) ramp 10.0 C
̊ /min to 25 C
̊ ; (2) isothermal for 120
mins; (3) end of the cycle. Click “Run” button to start the sequences.
The mass transfer coefficient, χ, were then calculated by:

𝜒=

−𝑚(𝑡)
𝐴∗𝑐(𝑡)

(3-3)

where m(t) is the mass of the solution, A is the area of the solution/air interface
(A~34.5 mm2 for standard TGA ceramic cup), and C(t) is the concentration of the
solution determined from the below equation:

𝑐(𝑡) =

𝑚(𝑡) −𝑚(𝑝𝑜𝑙𝑦𝑚𝑒𝑟)
𝑚(𝑡) /𝜌

(3-4)

Where m(polymer) is the mass of polymer in the solution and ρ is the density of the
solution.

Figure 3. 10 Image of QSeries software graphics interface under testing
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3.2.5 Fourier Transform Infrared Spectrometer (FT-IR)
Polymer composites and copolymers were characterized by Spectrum 100
Fourier Transform Infrared Spectrometer (PerkinElmer, Shelton, CT; Figure 3.11).
The physical properties of polymer composites and copolymer are affected by the
structure of the molecular chains. When infrared radiation passes through a
polymer sample, some of the radiation is transmitted while some radiation is
absorbed by the sample. The resulting spectrum of absorbed light represents a
distinctive “fingerprint” of the molecular structure of the sample and reveals the
information of intermolecular hydrogen bonding.

Figure 3. 11 Image of PerkinElmer Spectrum 100 FT-IR spectrometer
Sample films were prepared by casting 200 µL of 6% solution of each
polymer composites and copolymer in 2, 2, 2-Trifluoroethanol and chloroform,
respectively. Films were heated to 60 ̊C for 30 minutes and then left overnight at
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room temperature to remove residual solvent. A background run is required to
eliminate the H2O and CO2 band in the air. Unless otherwise noted, the spectrums
were obtained with 32 scans per sample ranging from 4000 cm -1 to 650 cm-1
(corresponding to wavelength from 2,500 nm to 15,000 nm).

3.2.6 Nuclear Magnetic Resonance (NMR) Spectroscopy
Copolymers were characterized by Varian Inova 400 MHz NMR (Agilent
Technologies, Santa Clara, CA; Figure 3.12). The NMR study could identify the
monomers’ ratios and the formation of new bonds.
The target copolymer sample (20 mg) was dissolved in 500 µL CDCl3 in an
NMR glass tube to form a slurry, which was then further sonicated to form a clear
solution. The ejection, insertion, spinning, locking, and shimming were all
controlled by VnmrJ Software. All 1HNMR spectra were acquired at frequencies of
399.8 MHz and conducted at 25 ̊C. The chemical shifts are reported in  (ppm)
values relative to CDCl3 ( = 7.26 ppm for 1H NMR).
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Figure 3. 12 Image of Varian Inova 400 MHz NMR

3.2.7 Scanning Electron Microscope (SEM)
The LEO Supra 35 VP field-emission variable pressure scanning electron
microscope (VPSEM) (Carl Zeiss, Oberochan, Germany; Figure 3.13A) and
VEGA 3 tungsten thermionic emission scanning electron microscope (TESCAN,
Brno, Czechia; Figure 3.13B) were both used to image and measure the
biopolymer fibers and observe the cell grow on the scaffold and in the extracellular
matrix. Despite the fact that the two SEMs have different electron sources, they
both work in a vacuum environment (10-4 - 10-5 Pa) and have “Secondary Beam”
detector. While the focused electron beam scans the sample, the secondary
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electrons are collected and converted to represent topographical imagery on the
screen.

Figure 3. 13 Image of A) Carl Zeiss Supra 35 VP field-emission SEM. B) TESCAN
VEGA 3 tungsten thermionic emission SEM
For a non-conductive sample, electron accumulation within the sample, or
"charging," often occurs, resulting in sample damage and reduced image quality.
Before the samples were loaded into the SEM chamber, they were all sputter
coated with a uniform thickness thin film of gold-palladium by the benchtop SPI
sputtering machine (Structure Probe, Inc., West Chester, PA; Figure 3.14) to
improve conductivity. The sample was first placed in a chamber filled with Argon
and then the chamber was vacuumed to ~80 millitorr. A visible discharge will be
observed when the plasma current was set to ~18 milliampere. To deposit a 10
nm-thick gold-palladium film, the sputtering time was set to 90 seconds.
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Figure 3. 14 Image of SPI-module sputter coater
The basic operations for these two SEMs are almost the same; however,
the software is different and requires individual training for each. The sputter
coated samples were attached to the desired stage platform with conductive
carbon tape and loaded into the SEM chamber. Upon completion of the vacuum
to reach the working air pressure, the working voltage and adjusted the working
distance are manually selected before starting imaging. Unless otherwise noted,
samples were observed with 2 – 10 KV working voltage and the working distance
of 8 – 12 mm.

3.2.8 Laser Cutting System
Several custom acrylic frames used for fiber fabrication and cell culture
were made by the LS1630 60-Watt CO2 laser cutting system (Boss Laser, LLC,
Sanford, FL; Figure 3.15). The X-Y-Z axis stage has an operational volume of 75
by 40 by 25 centimeters, respectively, with a positioning resolution of 0.025
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millimeters along all three axes. A 250 cubic foot per minute (CFM) exhaust fan
system is employed to vent the volatile fumes/particulates out of the laser cutting
system enclosure and safely into the building HVAC fume extraction system.

Figure 3. 15 Image of Boss LS1630 laser cutting system A) System body, B) Laser
cut under the working
The desired structure of interest was designed by SolidWorks and
converted the 3D part file into 2D Adobe Illustrator file (.AI). The .AI file is imported
into the RDWorks software. The laser head is positioned to the desired location
over material to be cut and adjusted the laser beam to focus on the top surface.
Set cutting speed and laser power with the Work tab. A power setting of 50% and
cutting speed of 10 mm/s is utilized for cutting 3 mm thick acrylic. The cell culture
frame with a recessed platform was achieved by two layers of operation (Figure
3.16). The first layer was to create the recessed platform by out of focus laser scan
mode; the second layer was to finally cut through the open window and boundary
by cut mode. The operation parameters are shown in Table 3.1.
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Figure 3. 16 Image of RDWorks software graphic interface with two layers of
operations: Red (scan) and Black (cut). The insert image shows the 3D part file of
the cell culture fiber frame with a recessed platform
Table 3. 1 The operation parameters for cell culture fiber frame with a recessed
platform
Laser mode

Focus (mm)

Speed (mm/s)

Power (%)

Scan

-10

300

40

Cut

0

10

50

3.2.9 Cell Culture Related Equipment
Cell culture, subculture, and seeding were all performed in the Biomimetics
& Tissue Engineering Laboratory at the University of Louisville (directed by Dr.
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Patricia Soucy, BSL-2). The main aseptic area is supplied by 1300 Series A2
Laminar-Flow Hood (Thermo Scientific, Waltham, MA; Figure 3.17) connected
with an aspiration pump and waste bottle. Cells were cryopreserved in VWR
CryoPro liquid nitrogen tank (Figure 3.18). Fisher Scientific ISOTEMP 210 Water
Bath (Set to 37 ̊C, Figure 3.19) was used to thaw the cells or prewarm a necessary
solution. Cells were incubated in the VWR CO2 incubator (Figure 3.20) with
controlled temperature (37 C
̊ ), high relative humidity (~ 60%) and elevated CO2
concentration (5.0%).

Figure 3. 17 Image of Thermo Scientific 1300 Series A2 Laminar-Flow Hood
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Figure 3. 18 Image of VWR CryoPro liquid nitrogen tank and the insert image
shows the drawers in a rack system inside of the tank

Figure 3. 19 Image of Fisher Scientific ISOTEMP 210 Water Bath
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Figure 3. 20 Image of VWR CO2 incubator
While performing the cell subcultivation, the cell suspension was
centrifuged by Allegra R Centrifuge (Beckman Coulter, Brea, CA; Figure 3.21) with
GH-3.8 swinging bucket rotors at 220 G (980 RPM) for 5 minutes to increase the
concentration or to wash off the reagent.

Figure 3. 21 Image of Beckman Coulter Allegra 6R Centrifuge
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Auto T4 Cellometer (Nexcelom Bioscience, Lawrence MA; Figure 3.22A)
was utilized to determine the cell concentration and mean diameter of the cells to
decide the seeding density. 20 µL of cell suspension was pipetted into the
compatible cellometer disposable counting chambers (Figure 3.22B) and inserted
into the cellometer. Select the cell types and click “Count” to get results (Figure
3.22C).

Figure 3. 22 Image of cell count: A) Nexcelom Auto T4 Cellometer, B) Nexcelom
disposable counting chambers, and C) Accessory software graphic interface
showed count results
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3.2.10 Epi-fluorescence Microscope
A TE2000-U inverted microscope (Nikon, Shinagawa, Japan; Figure 3.23)
with an X-Cite 120 fluorescence illumination system (Excelitas Technologies,
Waltham, MA) and QIMAGING Retiga 2000R CCD camera (Teledyne, Surrey,
Canada) was used to captured fluorescence images. This fluorescence
microscope system was installed with three filters (1) Blue filter shows FITC and
Alexa 488 (green colors); (2) Green filter shows Alexa Fluor 566 and Rhodamine
(red colors), and (3) Violet filter shows DAPI and Alexa Fluor 350 (blue color). Cell
samples need to be fixed first and then stained with different dyes prior to taking
images. 10X, 20X, and 40X objectives were all used for capturing different
magnification images.

Figure 3. 23 Image of Nikon TE2000-U inverted microscope with an X-Cite 120
fluorescence illumination system and QIMAGING Retiga 2000R CCD camera
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3.2.11 Confocal Microscope
An Eclipse Ti- A1R confocal microscope (Nikon, Shinagawa, Japan; Figure
3.24) was employed to generate three-dimensional views of cells on the scaffold
to evaluate if the cells could grow circumferentially around the fibers and if the
neighboring cells can form cell-cell junctions. This confocal microscope system
consisted of an inverted microscope and an A1R confocal laser system, which
including a laser source, scanner controller, scan head, stage joystick, LED source,
and a PC workstation. This confocal microscope system has three lasers excitation
and corresponding filters: (1) 403.8 nm for DAPI (show blue color), (2) 487.8 nm
for FITC (show green color), and (3) 561.6 nm for TxRed (show red color). 20X
and 40X objective were used for different magnification images, and both
objectives need to be immersed with oil. Accessory NIS Elements software could
switch the objectives, select the different channels and filters, adjust the focal
length and area, and change scanning speed. Unless otherwise noted, the pinhole
was set to 1.5 AU, the laser power of 4 channels + TD were set to 5%, gain (high
voltage) was adjusted between 60 to 120, and Offset was always set to 0. All zstacks were taken with a 0.2 µm step size. Similar to the fluorescence microscope,
all the samples need to be fixed and stained with different dyes. However, due to
the difficulty to transfer the scaffold onto standard microscope slides from a
standard well plate, and the limited depth of field of objectives for suspended
scaffolds, samples used for confocal imaging were all cultured and observed under
two walls Chambered Cover Glass System (Cole-parmer, Vernon Hills, IL. Growth
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area = 4.0 cm2 and the working volume = 1.5 mL; Figure 3.25). The ultra-thin (0.13
mm) cover glasses on the bottom permit viewing of the cells on the suspended
scaffolds.

Figure 3. 24 Image of Nikon Eclipse Ti inverted microscope with A1R confocal
laser system

Figure 3. 25 Image of the two walls Chambered Cover Glass System
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3.3 Methodology
3.3.1 Biopolymer Solution Preparation
The solvent selection is critical to fabricating the biopolymer fiber
successfully by using the direct-write technique. According to the previous
research in our group, the ideal solvent should meet the following two criterions:
(1) the capability of the solvent to dissolve the polymer within a range of
concentrations sufﬁcient for direct-write; (2) moderate volatility as deﬁned by a
boiling point ranging from 60 to 140 ̊C.
3.3.1.1 Gelatin, PLGA, and Composites’ Solution
Although there are a variety of organic solvents including polar and nonpolar solvent that could successfully dissolve PLGA, gelatin is only dissolved in
polar organic solvents such as 2,2,2-trifluoroethanol (TFE, BP = 78

̊C),

1,1,1,3,3,3-hexafluoro-2-propanol (HFIP, BP = 58.2 C
̊ ), and acetic acid (AA, BP =
118 C
̊ ) because it has strong polarity [196]. Thus, TFE and acetic acid were
chosen to perform preliminary experiments to figure out the optimal solvent for
direct-written micro-fibers.
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Figure 3. 26 Image of gelatin and PLGA and their composites solution in TFE

Gelatin Type A from porcine skin (gel strength 300), 2,2,2-trifluoroethanol,
ReagentPlus® grade, ≥99%), and acetic acid (≥99%) were all purchased from
Sigma-Aldrich (St. Louis, MO). 50:50 DL-PLGA was purchased from Lactel
Absorbable Polymers (Birmingham, AL). Gelatin solutions were produced by
dissolving powder gelatin into AA or TFE; PLGA solutions were produced by
dissolving granular PLGA in TFE; Gelatin/PLGA composite solutions were
produced by physically mixing the gelatin and PLGA at a weight ratio of 70:30 and
50:50 into TFE and maintained the whole concentration. All the solutions were
vortex stirred for 3 minutes for pre-mix and followed by magnetic stir for 6 hours at
room temperature. All the solutions were confirmed complete dissolution by
inspected homogeneity and optical clarity after stirring. The solution remained
clear after sitting for one week.
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3.3.1.2 PLA and PLA-PEG Copolymer’s solution
Polylactic acid (PLA, 3001D, melt flow index of 1.1@ 210 C
̊ ) and
Polyethylene glycol (PEG, molecular weight 1000) were kindly supplied by Dr.
Kunal Kate. Chloroform (≥99.8%) was purchased from Sigma-Aldrich (St. Louis,
MO). PLA-PEG (50:50) and PLA-PEG (90:10) were previously synthesized by Dr.
Kunal. PLA-PEG copolymers were synthesized by reacting the different ratio
components (Table 3.2) in a three-neck glass reactor at 205 C
̊ with stirring under
a nitrogen atmosphere for 4 hours. The copolymer synthesis setup is shown in
Figure 3.27. The resulting copolymer was cooled at room temperature and stored
under moisture-free conditions. A home blender was used to ground the copolymer
into a powder for solution preparation.
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Figure 3. 27 Image of PLA-PEG copolymer synthesis setup

Table 3. 2 Copolymer synthesis component mass ratio
Copolymers

PLA (g)

PEG (g)

PLA-PEG (75:25)

112.5

37.5

PLA-PEG (70:30)

105

45

PLA-PEG (60:40)

90

60
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Some non-polar organic solvents such as chlorobenzene (BP = 131 C
̊ ), 1,2dichloroethane (BP =84 ̊C), acetone (BP = 57 C
̊ ), and chloroform (BP= 61 ̊C) were
trialed to dissolve PLA and copolymers. All the solutions were vortex stirred for 3
minutes for pre-mix and followed by ultrasonication for 3 hours at room
temperature. Those solvents that could dissolve the polymer and copolymers at a
concentration larger than 20% were chosen to draw micro-fibers.

3.3.2 Scaffold Fabrication
3.3.2.1 Fabrication of Single Suspended Fiber
During the single suspended fiber fabrication process (Figure 3.28), the
polymer solution was expelled to form a polymer droplet that makes contact with
the substrate. The dispensing tip with polymer droplet then immediately was lifted
1 mm and laterally translated with a constant traveling velocity to the predefined
termination location on the other side of the substrate. The polymer droplet thinned
and elongated to form a filament by surface tension driven necking as defined by
the capillary drying process. Finally, the polymer solution was expelled again, and
the dispensing tip lowered down 1 mm to establish ending contact point.
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Figure 3. 28 Schematic illustrating (top) and real images (bottom) of the directwriting process. A) The polymer solution was expelled and contacted with the
substrate. B) The dispensing tip was translated to a predefined point while the
polymer filament undergoes surface tension driven necking. C) The polymer
solution was expelled again to establish the ending contact point.
3.3.2.2 Initial Polymer Drop Size and Needle-to-Substrate Gap
The initial polymer drop size and the needle-to-substrate gap was
determined experimentally by using USB-camera to capture and measure the
resulting polymer drop images. Four different polymer solution drops were expelled
under different valve open time: 0.02 s, 0.05 s, 0.1 s, and 0.5 s. The needle-tosubstrate gap was adjusted from 0 to 600 µm.
3.3.2.3 Fabrication of Branched Structure
The branch structure was fabricated as Figure 3.29. First, a single
suspended fiber was fabricated across an acrylic frame (Figure 3.29A). Then,
another fiber was drawn over top of the first fiber and lowered 2 mm to attach the
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two fibers (Figure 3.29B-C). Finally, the needle was lifted and translated to the
ending point to finish the structure construction (Figure 3.29D). The attachment of
the two fibers was in a very short period (~1 second) so that both fibers still possess
some solvent to promote the adhesion between the two fibers.

Figure 3. 29 Schematic illustrating and real images of the fabrication of the
branched structure

3.3.3 Empirical Model Generation
3.3.3.1 Theoretical Model
A direct-written fiber is created by thinning and elongation from the bulk
polymer solution, thus, understanding the polymer solution rheological properties
is essential to the capillary thinning process. McKinley et al. developed an early
model and showed that the filament would thin until capillary breakup when the
filament forms[197]. The mathematical model is given below:
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(2𝑋−1) 𝜎

𝐷(𝑡) = 𝐷1 −

3

𝜂

𝑡

(3-5)

Where D(t) is the diameter of polymer filament, D1 is the initial diameter of the
polymer filament, X is a constant which determined to be 0.7127 and 1 by two
different groups[198, 199], σ is the surface tension, η is the Newtonian viscosity,
and t is the filament formation time. This model illustrates the relationship between
the final polymer fiber diameter, the physical properties of the polymer, and
operation time. However, the high volatility for the solvent of the polymer solution
has not been considered.
Tripathi et al. further proposed a theory that introduces the evaporation rate
of the solvent into the model[200]. For a Newtonian solution, the equilibrium fiber
diameter 𝐷∞ is given as below:

𝐷∞ = 𝐷1 𝑒 −0.035/𝑃
𝑃=

𝜂𝜒
𝜎

(3-6)

(3-7)

Where P is defined as a dimensionless Processability parameter and χ is the
evaporation rate, also known as polymer solution’s mass transfer coefficient. The
model clearly shows that the high viscosity and high volatility will resist the thinning
process while the surface tension will induce the thinning process.
All the above models are established based on a simple polymer thinning
process with constant length and zero velocity, but the direct-writing process has
the ability to run at a different velocity and different length. The polymer fiber
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formation affected by an increased number of variables; thus, the Processability
parameter model should be augmented with additional dimensionless parameters
to solve this problem. According to the Buckingham Pi theorem, given a relation
among n parameters of the form:

g(q1, q2, ···, qn) = 0

(3-8)

The n parameters may be grouped into n – m independent dimensionless ratios,
or Π parameters, expressible in function form by:

G(Π1, Π2, ···, Πn-m) = 0

(3-9)

Which m is usually equal to a minimum number of independent dimensions
required to specify the dimensions of all the parameters.
Carefully inspecting the direct-writing process described in Figure. 3.28,
one dependent variable (fiber diameter, 𝐷∞ ) and five independent variables are
involved: the polymer solution viscosity (η), polymer solution surface tension (σ),
mass transfer coefficient (χ), feed rate (U), and fiber length (L). MLt (mass, length,
and time) was selected as fundamental dimensions set. Thus, this dimensional
analysis could be grouped into three dimensionless parameters (6-3=3).
Except for the Processability parameter, two additional dimensionless
parameters were introduced to the model to define the fiber drawing process:
Capillary number (Ca) and Aspect ratio (Λ), given as below:

𝐶𝑎 =

𝜂𝑈
𝜎
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(3-10)

𝛬=

𝐿

(3-11)

𝐷0

Where U is drawing velocity (feed rate) and D0 is the initial diameter of the polymer
droplet.
3.3.3.2 Design of Experiment
The design of experiments was conducted by using Minitab with two
important aims. The first aim was to investigate the influences of the four factors
(solution concentration, feed rate, the inner diameter of the needle (ID) and fiber
length) on the yield of the fiber. The second aim was to analyze the effect of the
P- Ca - Λ dimensionless system on the diameter of the direct drawing fiber and
further decide the optimal process parameters for to generate biopolymer fibers
with diameters within microvascular range (5 - 20 µm). The experiment design with
levels of factors is shown in Table 3.3.
Table 3. 3 Selected factors and their levels used in the design of experiments
Levels
Factors
No.

Variables

A, Concentration (wt.%)

3

15, 16, 17

B, Feed Rate (mm/s)

3

100, 200, 300

C, Needle ID (mm)

4

0.10, 0.15, 0.20, 0.25

D, Fiber length (mm)

12

2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 30, 40
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3.3.3.3 Model Generation
The physical properties of the gelatin solution, such as viscosity, surface
tension, and evaporation rate, were measured by the previously described
methods in section 3.2. Three dimensionless parameters--Processability
parameter (P), Capillary number (Ca), and Aspect ratio (Λ)--were calculated from
the determined polymer solution physical properties and the operational
parameters. The finished fibers array was sputter coated with a thin layer (t = 10
nm) of gold-palladium alloy and imaging by SEM. The diameters of each fiber were
measured and recorded at the middle point as well as 200 µm from the initiating
and terminating side; the average of these values was used as the final fiber
diameter. An ANOVA based on the gelatin characterization data was performed
using Minitab software to find out the factors that significantly affect the response.
Only those significant factors determined by the ANOVA were chosen to perform
the linear regression analysis to generate the empirical model and contour plots.
The empirical model included three dimensionless parameters (P - Ca - Λ), which
related micro-fiber diameter to five independent variables (viscosity, surface
tension, solvent evaporation rate, fiber length, and feed rate). Furthermore, the
adequacy of the regression model also was checked through Minitab.

3.3.4 Empirical Model Validation
Because the empirical model was generated using only one biopolymer
(gelatin), it is necessary to perform experiments with other biopolymers,
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composites, and copolymers in order to validate the empirical model. A list of the
biopolymers, solvents and their concentrations is shown in Table 3.4.
Table 3. 4 Biopolymers used to validate the gelatin-based empirical model
Concentration
Biopolymer composition

Solvent
(wt.%)

PLGA

TFE

25%

PLGA

TFE

26%

Gelatin/PLGA (70:30)

TFE

17%

Gelatin/PLGA (70:30)

TFE

18%

Gelatin/PLGA (50:50)

TFE

18%

Gelatin/PLGA (50:50)

TFE

19%

PLA

Chloroform

28%

PLA

Chloroform

29%

PLA-PEG (75:25)

Chloroform

20%

PLA-PEG (75:25)

Chloroform

21%

PLA-PEG (70:30)

Chloroform

30%

PLA-PEG (70:30)

Chloroform

31%
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Based on the previous optimal results, the needle with an inner diameter of
0.25 mm was chosen for the fiber fabrication. Micro-fibers array with lengths of 4,
6, and 8 mm (each length for three fibers) were drawn at a feed rate of 200 mm/s
for all biopolymer solutions. The biopolymer solution physical parameters and
dimensionless parameters (P - Ca - Λ) were measured and calculated as previously
described for the gelatin solution. The prediction data was then gathered by input
of the dimensionless parameters into the empirical model. The experimental fiber
diameters were also measured in three points by SEM as previously introduced in
section 3.3.3.3. Then the experimental data was compared with the values
predicted by the empirical model.

3.3.5 Cells Seeding on Scaffold
3.3.5.1 Cell Culture and Reagents
Human Dermal Microvascular Endothelial Cells (HDMECs) (PromoCell
GmbH, Heidelberg, Germany) were cultured in Endothelial Cell Growth Medium
MV kit with growth supplement containing Fetal Bovine Serum (0.05 mL/mL),
Epidermal Growth Factor (5 ng/mL), Basic Fibroblast Growth Factor (10 ng/mL),
Vascular Endothelial Growth Factor 165 (0.5 ng/mL), Ascorbic Acid (1 µg/mL), and
Hydrocortisone (0.2 µg/mL) (PromoCell GmbH, Heidelberg, Germany). The
antibiotic-antimycotic containing 10,000 units/mL penicillin and 10,000 µg/mL
streptomycin (GE Healthcare Bio-Sciences, Pittsburgh, PA) was also added to the
medium kit with the growth supplement. 0.05% Trypsin/0.53 mM EDTA (Mediatech,
Inc. Manassas, VA) was used to detach the cells when subculturing the cells.
93

One vial of cryopreserved HDMECs (~500,000 cells) was thawed for 3
minutes in a water bath (37 ̊C). Then, the cell solution was pipetted into a T-25
flask with 8 mL of growth medium and cultured for 2 days in the incubator (37 C
̊ ,
5% CO2). Once it had reached 90% confluency, the cells were passaged into a T75 flask by using 1mL of 0.05% trypsin solution. The media was changed every
two days. In 90% confluency, the cells were passaged again by 2 mL of 0.05%
trypsin solution and 2 mL of media was added to obtain a total of 4 mL cells
suspension solution. Cellometer was utilized at least twice to check the cell density,
then the cells with known density could be seeded on the substrates of interest. All
cells in this study were used between passages 3 and 8.
3.3.5.2 Biodegradation Test
Generally, it will take 6 months to 2 years to fully degrade PLA and
PLGA[56]. Thus, it is very important to understand the degradation behavior of the
biopolymers, composites, and copolymers. Using a bench top compression
molding (Figure 3.30A), each biopolymer, composites, and copolymer were cast
into several 15 mm diameter by 10 mm high cylinders (Figure 3.30B). Each
sample cylinder was placed in a Petri dish and incubated with 15 mL of 1X
phosphate-buffered saline (PBS) solution at body temperature (37°C) for up to 8
weeks. PBS solution was changed every week to eliminate the acidic
biodegradation products. At the end of each week, the sample cylinders were
rinsed with DI water and vacuum dried for 30 minutes, then the mass lost were
recorded to obtain the short-term degradation profiles.
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Figure 3. 30 Image of sample molding: A) Benchtop compression molding, B)
example of molded PLA-PEG (75:25) sample cylinder
3.3.5.3 Biopolymers Cellular Adhesion/Viability Test
To evaluate if the chosen biopolymers, composites, and copolymers were
suited for the HDMECs growth, a cellular adhesion test was performed. 400 µL of
6% biopolymers solutions were deposited in the 24-well plate to form films. The
films were then heated to 65 ̊C for 30 minutes and then left for 3 days in vacuum
at room temperature to further remove residual solvent. Each film was sterilized by
UV light exposure for 1 hour, coated with 200 µL of 5 µg/mL fibronectin aqueous
solution, and incubated for 1 hour at 37 ̊C. After aspirated the fibronectin solution
and washed with 1X PBS twice, HDMECs were seeded on each of the films at a
density of 40,000 cells/cm2 (76,000 cells for each plate of a 24-well plate, bottom
surface area = 1.9 cm2) and incubated for 24 hours at 37 ̊C. To count the quantity
of the adhered cells on the film, each sample was fixed and stained with 4’,6diamidino-2-phenylindole (DAPI). To check the cell viability, each sample was
stained with a live/dead assay. The details of the staining procedure will be
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introduced on section 3.3.5.6. Fluorescent images were taken by the fluorescent
microscope and analyzed by ImageJ software.
3.3.5.4 Cell Seeding Conditions
The basic idea of seeding cells on the scaffold is to submerge the scaffold
in cell suspension and growth medium within a container, such as a 24-well plate
or a chambered cover glass system. Three cell seeding conditions were studied to
develop the optimal protocol for cell seeding onto the scaffold: (1) cells blocking,
(2) adhesion promoters, and (3) cell seeding density.
To reduce the attached cells on the bottom of the container, bovine serum
albumin (BSA) was used to block the bottom of the container. 0.2 mL of 0.01%,
0.1%, and 1% of BSA (Sigma, St. Louis, MO) solution in 1X PBS was first added
into the 24-well plate to cover the bottom of the well and incubated for 1 hour at
37 C
̊ . After aspirating the BSA solution, HDMECs were then seeded at a density
of 40,000 cells/cm2 and incubated for 24 hours at 37 ̊C.
Gelatin attachment factor and fibronectin are often used to coat culture
surfaces to enhance the adhesion and growth of microvascular endothelial
cells[201]. To evaluate the effectiveness of the cell adhesion promoters, cellular
adhesion quantification experiments were conducted on both polymer films and
fibers. Polymer films were fabricated in the 24-well plate through solvent casting
from 400 µL of 6% PLA-PEG (75:25) copolymer solution in chloroform. Polymer
fibers were fabricated on a custom cell culture fiber frame with a recessed platform
via the direct-write system from 20% PLA-PEG (75:25) copolymer solution in
chloroform. Each film and fiber was coated with 200 µL of 1x gelatin attachment
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factor (AF, Cascade, Thermo Fisher Scientific, Waltham, MA), 5 µg/mL fibronectin
(FN, Thermo Fisher Scientific, Waltham, MA) aqueous solution, and combined two
promoters and then incubated for 1 hour at 37 ̊C. After aspirating the adhesion
promoter solution, HDMECs were then seeded at a density of 40,000 cells/cm2
and incubated for 24 hours at 37 ̊C.
The micro-fiber scaffold will ultimately be submerged in the cell suspension
during experimentation to capture the floating cells randomly. Thus, the seeding
density may affect the final output of the cell adhesion. Three parallel PLA-PEG
(75:25) micro-fibers with a distance of 2 mm were fabricated on the custom cell
culture fiber frame with a recessed platform via the direct-write system. Each fiber
was coated with 200 µL of 5 µg/mL fibronectin aqueous solution and incubated for
1 hour at 37 C
̊ . Then, the fibronectin-coated fibers were transferred into a 0.1%
BSA (incubated for 1 hour at 37 ̊C) pre-treated 24-wall plate. HDMECs were then
seeded at a series seeding density: 40,000 cells/cm 2, 60,000 cells/cm2. 80,000
cells/cm2, and 100,000 cells/cm2. The cells were all incubated for 24 hours at 37 C
̊ .
For each of the experiments described, the number of attached cells was
compared by the fluorescent images after the cells were fixed and stained with
DAPI. Stained nuclei were counted by ImageJ software. Student t-tests were
performed to identify the optimal seeding recipe.
3.3.5.5 Cell Seeding on the Scaffold
The fabricated scaffold on the custom frame was left under vacuum for
overnight to make sure no residual solvent was left. Firstly, the custom frame was
flipped (the recessed platform toward down) and put into a 24-well plate followed
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by exposed under UV light in the laminar-flow hood for 1 hour. After the sterilization,
the scaffold was covered with 0.1 mL of 5 µL/mL fibronectin solution and incubated
at 37 C
̊ for 1 hour. At the same time, another 24-well plate was covered with 0.1
mL of 0.1% BSA solution and put into the incubator for 1 hour. Then, the fibronectin
solution and BSA solution were aspirated along the inner wall of the well, and the
fibronectin-coated scaffold was transferred carefully by a sterile tweezer to the
BSA-coated well. This process needs to be completed extremely carefully because
the scaffold is very easy to be broken by the vacuum or the surface tension induced
by the meniscus of residual liquid. The procedure of 3.3.5.1 was followed to obtain
enough HDMECs suspension with known cell density. For a 24-well plate (bottom
surface area = 1.9 cm2), each wall needed to be seeded with 1.524 x 105 cells to
reach a cell density of 80,000 cells/ cm2. The desired cell suspension volume was
calculated based on the cell density. Then, the cell suspension was gently seeded
on the scaffold, and the fresh media was added to the working volume (0.5 ml for
24 wall plate). The 24-well plate was placed into the incubator while slowly rocking
on a nutating mixer (Thermo Fisher Scientific, Figure 3.31) for 1 day to improve
the cell adhesion, followed by 1 day of incubation without the rocking.
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Figure 3. 31 Cells seeded on the scaffold with slow rocking on a nutating mixer in
the incubator

3.3.5.6 Immunofluorescent Staining
Unless otherwise noted, all the samples observed under the fluorescent
microscope and confocal microscope were first washed by 1X PBS for 1 minute,
fixed by 3.7% formaldehyde for 10 minutes at room temperature, and then
permeabilized in 0.1% Tween 20 for 5 minutes.
3.3.5.6.1 DAPI and Rhodamine Phalloidin Staining
The nucleus was stained by DAPI (300 µM, courtesy of Dr. Patricia Soucy)
and the cytoskeleton was stained by rhodamine phalloidin (200 units/ml, Invitrogen,
Thermo Fisher Scientific, Waltham, MA). The DAPI and rhodamine phalloidin was
thawed, then diluted in 1X PBS (1:5) and 0.1% BSA solution (1:50), respectively.
Each sample was incubated at 37 ̊C for 30 minutes in 0.1 mL of the diluted
rhodamine phalloidin solution. The sample was covered properly to avoid solution
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evaporation. After removing the rhodamine phalloidin solution and washing the
sample twice with 1X PBS, 0.1 mL of diluted DAPI solution was added to cover the
sample and standing for 3 minutes at room temperature. After washing three times,
0.5 mL fresh 1X PBS was added to submerge the sample.I Imaging on the
fluorescent or confocal microscope occurred immediately after. All the steps above
were finished in the dark to protect the fluorescent dyes from light exposure. The
best staining result was achieved by performing the fixation and staining on the
same day.

3.3.5.6.2 VE-Cadherin Staining
VE-Cadherin staining was used to analyze the cell-cell junctions of cells
adhered to the scaffold. Firstly, the primary antibody was prepared by diluting
rabbit anti-VE cadherin (AB-33168, courtesy of Dr. Patricia Soucy) in 0.1% BSA
(1:50). The secondary antibody was prepared by adding goat-anti-rabbit IgG Alexa
Fluor 488 (A-11034, courtesy of Dr. Patricia Soucy) to 0.1% BSA with a dilution of
1:40. Then, each sample was incubated at 37 C
̊ for 30 minutes in 0.1 mL of the
primary antibody. The sample was covered properly to avoid solution evaporation.
Following 3 minutes of washing with 1X PBS, 0.1 mL of the secondary antibody
was added to cover the sample and continued to incubate at 37 ̊C for 30 minutes.
After washing another 3 minutes with 1X PBS, the samples were visualized using
the confocal microscope with 0.5 mL fresh PBS as an anti-fade solution. All the
steps above were finished in the dark to protect the antibodies from the light
exposure.
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3.3.5.6.3 Live/Dead Assay
Live/dead assay (Invitrogen MP 03224, courtesy of Dr. Patricia Soucy) was
used to study the cellular adhesion on different biopolymers as well as to check
the viability of the cells on the scaffold in the ECM. The live cells are distinguished
by the presence of ubiquitous intracellular esterase activity, determined by the
enzymatic conversion the virtually nonfluorescent cell-permanent Calcein AM to
the fluorescent calcein. EthD-1 enters cells with damaged membranes and
undergoes a 40-fold enhancement of fluorescence upon binding to nucleic acids.
EthD-1 is excluded by the intact plasma membrane of live cells.
The sample for this experiment cannot be fixed. In addition, the staining
solution should be made fresh each time in the laminar-flow hood and need to be
protected from light exposure. By calculating the desired volume of staining
solution, ethidium homodimer-1 (2 mM) was diluted to 4 µM, and Calcein AM (4
mM) was diluted 2 µM in the same vial in serum-free media 200. After gently
washing the cells with serum-free media 200 twice, 0.1 mL of the staining solution
was added to cover the whole sample and incubated at 37 ̊C for 30 minutes. Then,
the samples were ready to be viewed under the fluorescent microscope.

3.3.5.7 Sample Preparation for SEM
All the chemicals used in this experiment were purchased from Electron
Microscopy Sciences (Hatfield, PA). The experiment needed to be conducted in
a fume hood for safety purposes. The cell-covered scaffold was gently washed
with 1X PBS for 1 minute, then fixed in 2% paraformaldehyde, 2% glutaraldehyde,
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0.1 M sodium cacodylate, and 3 mM sodium chloride (pH 7.4) at room temperature
for 1 hour while slowly rocking. After washing with 1X PBS for 10 minutes, the
sample was post-fixed in 0.8% potassium ferrocyanide-reduced 1% osmium
tetroxide, 0.1 M sodium cacodylate, and 3 mM sodium chloride for 1 hour on ice in
the dark. Following the DI water rinse (twice, 5 minutes each), the sample was
then placed in 2% uranyl acetate-aqueous (0.22 µm filtered) for 1 hour at room
temperature in the dark. Then, the sample was dehydrated through a graded series
of ethanol with the following schedule: washed by 50%, 70%, and 90% ethanol 5
minutes each, then washed by 100% ethanol three times for 5 minutes each. Upon
completing the ethanol treatment, the sample was further dehydrated by washing
with 0.5 mL hexamethyldisilazane (HMDS) for 5 minutes. After the HMDS was
drained, the sample was placed in a desiccator overnight until it was completely
dried. The sample received a 10 nm thick gold-palladium sputter coating before
being observed under the SEM.

3.3.6 Cells and Scaffold Embedded in ECM
3.3.6.1 Collagen Gel Solution Preparation
Type I collagen (rat tail, 8.34 mg/mL, Corning, NY) was used to work as
ECM in this project. To prepare a 1 mg/mL collagen gel solution, the following
components (courtesy of Dr. Patricia Soucy, Table 3.5) were added into a tube on
ice and mixed for 1 minute with a pipette. NaOH was used to adjust the pH to 7.4
and DI water was used to make the desired volume. The collagen gel solution was
made freshly 5 minutes before encapsulating the cell-covered scaffold.
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Table 3. 5 Collagen Gel Solution Components

Stock

Example volume for

Concentration

400 µL solution

NaHCO3

10 mg/ml

20 µL

Collagen

8.34 mg/ml

48 µL

PBS

10 X

40 µL

HEPES

2M

2 µL

NaOH

1M

15 µL

DI water

-

275 µL

Components

3.3.6.2 Gelation and Cell Culture
To prevent the cells on the bottom of the well plate from migrating to the
deposited collagen gel and interfering with imaging, the cell-covered scaffold
needed to be transferred into a new container for ECM gelation. First, gently
aspirated the medium along the inner wall of the 24-well plate to avoid damage to
the scaffold induced by the liquid surface tension. Then, the cell-covered scaffold
was washed by 1X PBS solution and carefully transferred into a new 24-well plate
or chambered cover glass system by a sterile tweezer. Slowly, 0.1 mL freshly
prepared collagen solution was added to fully cover the scaffold; samples were
incubated for 35 minutes at 37 ̊C. After gelation finished, the desired amount of
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media was added to a 24-well plate (0.5 mL) or a chambered cover glass system
(1.5mL), and then continued to incubate for an additional 3 days. The media was
changed every two days.
3.3.6.3 Imaging Samples Preparation
After the cells on the scaffold are cultured in the collagen gel for 3 days,
fluorescent images were obtained by the fluorescent microscope and the confocal
microscope to observe the cells growth in the ECM. The staining procedures were
similar to the previously described in section 3.3.5.6. However, the fixation time,
washing time, and staining time need to be doubled due to the slow diffusion in the
collagen gel.
To observe the ECM-cells-scaffold interaction and evaluate the scaffold
degradation, SEM cross-sectional images of the scaffold embedded in collagen
gel were captured. The procedure of section 3.3.5.7 was followed, butafter the
HMDS treatment, the collagen gel film was still soft. If the gel film was left on the
frame until it was completely dry, the film may tear or warp and would not be usable.
To safely preserve the sample, the four sides of the gel film were gently cut and
carefully transferred on to a PTFE surface. After the gel film completely dried, it
was cut perpendicular to the scaffold axis with a sharp blade. The sample was
attached onto a vertical SEM specimen stage and a 10 nm thick gold-palladium
sputter coating was applied before being observed under the SEM.
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CHAPTER 4: RESULTS AND DISCUSSION
In this chapter, the results associated with the specific aims outlined in the
introduction will be examined. First, the fabrication results of the biopolymer microfibers and branch structures will be presented. Next, the direct-write process will
be characterized through the design of experiments (DOE), and an analysis of
variance (ANOVA) will be conducted to determine the significant factors that are
affecting the micro-fiber diameter. In the course of this investigation, an empirical
model will be developed and validated to predict the micro-fibers diameter through
the dimensional analysis. Then, the growth of the Human Dermal Microvascular
Endothelial Cells (HDMECs) on the scaffold will be evaluated after culturing for 2
days. Finally, the scaffold degradation and the ECM-cell-scaffold interactions will
be evaluated once the cell-covered scaffold is embedded into the collagen gel.
4.1 Fabrication of Biopolymer Micro-fibers and Branch Structures via 3-Axis
Robotic Dispensing System
It has been more than a decade since our group began to study the directwriting technique. Dr. Scott Berry first employed the Ultra-High Precision
Micromilling Machine (UHPMMM) to generate micron-sized fibers from
poly(methyl methacrylate) (PMMA) as well as a variety of biopolymers such as
polycaprolactone (PCL), polylactic acid (PLA), and poly(lactic-co-glycolic acid)
(PLGA)[181]. Furthermore, Dr. Hanwen Yuan utilized the 3-Axis robotic dispensing
system to produce micro-/nano-fibers from PMMA and demonstrated the ability to
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reach a higher yield compared to using the previous UHPMMM method[202]. In
this project, we adopted the 3-Axis robotic dispensing system and successfully
fabricated precisely-positioned, suspended micro-fibers and branched structures
with microvascular-scale diameters from several natural, synthetic, and
composites biopolymers.
4.1.1 Gelatin, PLGA, and Composites
Before the micro-fibers were produced, the optimal solvent was firstly
identified for gelatin since there are a limited number of polar organic solvents with
moderate volatility. Table 4.1 shows the solvent and concentration trials for gelatin.
The acetic acid solution was excluded due to the poor fiber drawing ability. 2,2,2trifluoroethanol (TFE) was ultimately chosen based on the increased solubility
characteristics of the gelatin and the fiber drawing ability. If the concentration is too
high, the solution was observed to be very thick. The majority of the drawing
attempts at the higher concentrations showed tensile failure and began to coil due
to the lack of solvent during the drawing (Figure 4.1A). On the contrary, if the
concentration is too low, the solution was observed to be very thin. Most of the
drawing attempts at the low concentration experienced breakup failure, which may
be caused by not having enough polymer in the solution to form the micro-fiber
(Figure 4.1B).
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Table 4. 1 Solvent and concentration trials for gelatin
Concentration Solvent

Solution comments

Fiber drawing ability

22%

Two phases, form gel

X

20%

Very thick gel

X

18%

Dissolve well, very thick

X

Dissolve well, flow well

✓

16%

Dissolve well, flow well

✓

15%

Dissolve well, flow well

✓

14%

Dissolve well, very thin

X

32%

Cannot dissolve, sediment

X

30%

Very thick gel

X

28%

Dissolve well, very thick

X

27%

Dissolve well, flow well

X

26%

Dissolve well, flow well

✓

25%

Dissolve well, very thin

X

17%

TFE

AA
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Figure 4. 1 SEM images of gelatin fibers drawn from the solutions which were: (A)
very thick and (B) very thin.
Once the solvent for gelatin was selected, the TFE solution concentrations
for PLGA and gelatin/PLGA composites were also identified by trials, similar to the
initial gelatin micro-fibers. These results are listed in Table 4.2.
Table 4. 2 TFE solution concentration trials for PLGA and gelatin/PLGA
composites
Concentration

concentration

Solution

Fiber drawing ability

PLGA

24%

Very thin

X

PLGA

25%

Dissolve well

✓

PLGA

26%

Dissolve well

✓

PLGA

27%

Dissolve well

X

Gelatin/PLGA (70:30)

17%

Dissolve well

✓

Gelatin/PLGA (70:30)

18%

Dissolve well

✓

Gelatin/PLGA (70:30)

19%

Dissolve well

X
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Gelatin/PLGA (50:50)

18%

Dissolve well

✓

Gelatin/PLGA (50:50)

19%

Dissolve well

✓

Gelatin/PLGA (50:50)

20%

Two phases

X

Suspended gelatin, PLGA, and their composite micro-fibers with
microvascular-scale diameters were successfully fabricated by the direct-write
technique via the 3-axis robotic dispensing system. Figure 4.2A showed the
gelatin droplet as the contact point and the end of the fiber, where the surface
tension thinning began. It can also be observed in the PLGA fibers and
gelatin/PLGA composite fibers. Figure 4.2B shows a single gelatin micro-fiber with
a diameter of 14.46 µm (processing factors: solution concentration = 17%, needle
ID = 0.25 mm, feed rate = 200 mm/s, and fiber length = 6 mm). Figure 4.2C shows
one PLGA micro-fiber with a diameter of 6.88 µm (processing factors: solution
concentration = 27%, needle ID = 0.20 mm, feed rate = 300 mm/s, and fiber length
= 8 mm). Figure 4.2D shows a single gelatin/PLGA composites fiber with a
diameter 7.15 µm (processing factors: solution concentration = total 16% with
gelatin/PLGA ratio of 70:30, needle ID = 0.25 mm, feed rate = 100 mm/s, and fiber
length = 6 mm). According to the SEM images, these different biopolymer microfibers all show a smooth cylindrical and bead-free morphology. The addition of
PLGA to gelatin does not affect the surface microstructure.
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Figure 4. 2 SEM images of the biopolymer micro-fibers fabricated with the 3-Axis
robotic dispensing robotic system. A) End of gelatin fiber, B) gelatin micro-fiber
with a diameter of 14.46 µm, C) PLGA micro-fiber with a diameter of 6.88 µm, and
D) gelatin/PLGA (70:30) composite fiber with a diameter of 7.15 µm
To further demonstrate the direct-write technique has the ability to precisely
control the micro-fibers’ three-dimensional spatial position, freely suspended
branched structures with different branching angles (60 ̊, 120 ,̊ and 150 ̊) were
designed and fabricated on the acrylic frame. Figure 4.3A-C shows the fabricated
gelatin branched structures with measured branching angles of 63 ̊, 116 ,̊ and 139 ,̊
respectively (processing factors: solution concentration = 16%, Needle ID = 0.20
mm, feed rate = 100 mm/s and fiber length = 8 mm). The relative errors for the
actual angles of these branched structures are 5.0%, 3.3%, and 7.3%, respectively.
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In section 2.1.1, we have learned that the capillary system consists of
arterioles, capillaries, and venules, and those vessels have different diameter
ranges. Thus, further developing a branched structure with varying diameters of
micro-fiber could better mimic the real capillary system structure. One of the
limitations of this 3-Axis robotic dispensing system is that the solution (i.e.,
concentration) and the needle cannot be changed during the fabrication process.
However, the fiber diameter could still be controlled by varying the feed rate.
Figure 4.3D shows a gelatin branched structure with a vertical supported fiber to
mimic the arteriole (processing factors: solution concentration = 16%, Needle ID =
0.20 mm, feed rate = 30 mm/s), whereas the branched fibers (Figure 4.3A-C)
could work as the capillary. (remain other processing factors the same except for
feed rate increase to 100 mm/s). Similarly, Figure 4.3E-F shows branched
structures with different fiber diameters fabricated from gelatin/PLGA composites
(70:30) and PLGA, respectively. Another factor that would affect the fiber diameter
is the fiber length. Generally, the branched fibers are longer than the supported
fiber (i.e., two times longer for the 60 ̊ branched structure) and have more
touchdown point, which may cause extra stress and displace the supported fiber.
Combined with different drawing speed, the different fiber diameters were
achieved in one branched structure.
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Figure 4. 3 SEM images of the gelatin branched structures with different branching
angles: A) 62.37 ,̊ B) 115.96 ̊, and C) 139.42 ̊, and branched structures with
different fiber diameters fabricated from: D) gelatin, E) gelatin/PLGA composites
(70:30), and F) PLGA.

The infrared spectra of the pristine gelatin, PLGA, and their composites are
presented in Figure 4.4. The characteristic absorption bands for N-H stretching at
3291.78 cm-1, amide I, C-O and C-N stretching at 1636.66 cm-1, and amide II, NH in-plane bending and C-N stretching at 1523.73 cm-1 could be found in the
pristine gelatin and the different composites. The typical absorption bands for ester
carbonyl stretching and vibration at 1749.91 cm-1 and C-O-C ether group stretching
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at 1084.34 cm-1 were also found in pure PLGA and the composites. Increasing the
amount of PLGA caused the intensity of C-O stretching and C-O-C group
stretching peaks to decrease. No new peak or peak shifting was observed in the
composites. This suggests that there is no new bond formed or strong chemical
interaction occurred within the composites, which confirms the gelatin/PLGA
composites are just simply a physical mixture.

Figure 4. 4 FT-IR spectra of pristine gelatin, PLGA, and their composites

4.1.2 PLA and PLA-PEG Copolymers
Similarly, the optimal solvent selection for PLA and PLA-PEG copolymer
was determined over several trials. Table 4.3 shows whether these polymer or
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copolymers are soluble in the common organic solvents at a concentration of at
least 20% by weight.
Table 4. 3 Solvent trials for PLA and PLA-PEG copolymers

Polymers TFE Chlorobenzene
PLA

1,2
Dichloroethane

Chloroform Acetone

X

X

✓

✓

X

X

X

✓

✓

X

X

X

X

✓

X

X

X

X

✓

X

X

X

X

✓

X

X

X

X

✓

X

PLA-PEG
(90:10)
PLA-PEG
(75:25)
PLA-PEG
(70:30)
PLA-PEG
(60:40)
PLA-PEG
(50:50)

Chloroform was ultimately chosen based on the increased solubility of the
polymers and moderate solvent volatility. Based on the preliminary experiments of
copolymer degradation and fiber drawing ability, only PLA-PEG (75:25) and PLAPEG (70:30) were selected to draw the micro-fibers. PLA-PEG (75:25) solution
was prepared by dissolving powder copolymer in chloroform of 20% and 21% by
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weight; PLA-PEG (70:30) solution was prepared by dissolving powder copolymer
in chloroform of 30% and 31% by weight. PLA solutions were prepared by
dissolving bead-shaped PLA in chloroform of 28% and 29% by weight (Table 4.4).
Table 4. 4 Selected concentration of PLA and PLA-PEG copolymer
Polymers

Solvent

Concentration

PLA

Chloroform

28%

PLA

Chloroform

29%

PLA-PEG (75:25)

Chloroform

20%

PLA-PEG (75:25)

Chloroform

21%

PLA-PEG (70:30)

Chloroform

30%

PLA-PEG (70:30)

Chloroform

31%

PLA and the selected PLA-PEG copolymers solutions were successfully
processed into suspended micro-fibers with a microvascular-scale diameter by
direct-write technique. Figure 4.5A presents the single suspended PLA micro-fiber
with a diameter of 15.47 µm (processing factors: solution concentration = 28%,
needle ID = 0.25 mm, feed rate = 100 mm/s, and fiber length = 6 mm); Figure 4.5B
shows the PLA-PEG (75:25) copolymer micro-fiber with a diameter of 9.05 µm
(processing factors: solution concentration = 21%, needle ID = 0.25 mm, feed rate
= 100 mm/s, and fiber length = 8 mm); Figure 4.5C demonstrates the PLA-PEG
(70:30) micro-fibers with a diameter of 6.52 µm (processing factors: solution
concentration = 31%, needle ID = 0.25 mm, feed rate = 100 mm/s, and fiber length
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= 10 mm). The SEM images indicate the produced micro-fibers have a smooth
surface and no bead was observed for most of the surface.

Figure 4. 5 SEM images of representative single suspended micro-fibers fabricated
by the 3-Axis robotic dispensing system. A) PLA fiber with the diameter of 15.47
µm, B) PLA-PEG (75:25) fiber with the diameter of 9.05 µm, and C) PLA-PEG
(70:30) fiber with the diameter of 6.52 µm.
PLA and PLA-PEG copolymer were also used to produce suspended
branched structures. Figure 4.6A-B shows PLA and PLA-PEG (75:25) copolymer
branched structures both with a vertical supported fiber and the branched fibers,
respectively (processing factors for PLA: solution concentration = 28%, needle ID
= 0.25 mm, feed rate = 100 mm/s; processing factors for PLA-PEG (75:25
copolymer): solution concentration = 21%, needle ID = 0.25 mm, feed rate = 100
mm/s. All supported fibers length = 8 mm).
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Figure 4. 6 SEM images of the representative branched structures fabricated by
the direct-write technique from different biopolymers. A) PLA; B) PLA-PEG (75:25)
copolymer. Inserted images showed the enlarged intersection area.

Besides producing single intersection branched structures, the 3-Axis
robotic dispensing system is able to generate several complex structures by
precisely controlling the dispensing tip to move among the predefined spatial spots,
including the initiating, terminating, and intersection points. Figure 4.7A shows a
web structure with triple intersections and all the branching angles designed to 90 .̊
The actual angles for those three branched fibers are 88.9 ̊, 84.7 ,̊ and 100.3 ̊, with
a relative error of 0.9%, 4.4%, and 8.6%, respectively. The relative error increased
with the drawing order; the probable reason is that the tension induced from the
previous fiber may move the supported fiber and lead the displacement of the
following fiber. Figure 4.7B demonstrates a dual-intersections branched structure
with different branching angles (designed to 60 ̊ and 120 ̊). The measured angles
are 59.2 a
̊ nd 113.9 ̊, with a relative error of 1.3% and 5.1%, respectively. Figure
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4.7C-D shows the parallel fiber arrays and overlapping fibers with orthotropic
structure, in which all fibers in those structures are within the microvascular-scale
diameters. Although those two structures are not similar to the real capillary system,
they still have the potential application value such as to be used to study the
angiogenesis behaviors of the endothelial cells between neighboring vessels.

Figure 4. 7 SEM images of complex suspend structures fabricated from PLA-PEG
(75:25) copolymer by direct-write technique. A) A branched structure with triple
intersections; B) a dual-intersections branched structure; C) parallel fibers array;
and D) overlapping fibers with orthotropic structure.
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The pristine PLA, PEG, and PLA-PEG copolymers were characterized by
using FT-IR and 1H-NMR. The infrared spectrum is presented in Figure 4.8. A
strong absorption peak at 1746.77 cm-1 was observed in the PLA, which confirmed
the presence of the ester stretching. Meanwhile, the FT-IR spectrum of PEG and
the copolymers showed characteristic peaks at 2887.45 cm-1 and 3458.25 cm-1,
which correspond to C-H stretching and terminal hydroxyl group O-H stretching,
respectively. For the series of copolymers, the ester stretching peaks could be
seen at 1757.88 - 1759.32 cm-1. The peaks shifting indicate the formation of the
copolymers. The C-H stretching and O-H stretching peaks were also observed in
those copolymers between 2885.36 - 2888.12 cm-1 and 3456.11 – 3459.43 cm-1,
respectively. The intensity reduction of these two peaks also suggests there may
be a new bond formed from the weak chemical interaction between the PLA and
PEG in the copolymer.
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Figure 4. 8 FT-IR spectra of pristine PLA, PEG, and PLA-PEG copolymers

To further confirm the copolymer formation, the 1H-NMR spectra of pristine
PLA, PEG, and PLA-PEG copolymers are also shown in Figure 4.9 (stacked
images with 15 ̊ tilt). For the PLA micro-fibers, the chemical shift at 5.15 ppm and
1.52 ppm was observed, which corresponded to CH- and CH3- bond, respectively.
The calculated integration ratio for these two peaks is 1:3.1, which confirms the
two types of hydrogen protons found in the chemical structure of PLA. For the PEG
micro-fibers, we found a single peak with a chemical shift at 3.63 ppm, which
indicates the CH2- bond. The series spectra of the copolymers show new peaks at
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4.29 ppm. We speculate those peaks corresponded to the CH 2-O hydrogen
protons from the newly formed ester bond (highlighted with the red circle in Figure
4.9). The new ester may be formed between the break of C(O)-O bond from PLA
and CH2-OCH2 bond from PEG. In general, the intensity of the new peaks shows
a reduction trend with the decreasing concentration of PEG, which suggests
incomplete copolymerization due to the lack of the CH2-OCH2 bond from PEG. We
also performed a polymer molecule NMR simulation by ChemNMR 1H Estimation
(Figure 4.10). For the given copolymer molecule with an ester group, a chemical
shift appears at 4.27 ppm; this trend is observed in our actual 1H-NMR spectra of
those copolymers.
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Figure 4. 9 1H-NMR spectra of PLA, PEG, and PLA-PEG copolymer
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Figure 4. 10 ChemNMR 1H Estimation of the formed copolymer

4.2 Characterization and Modeling of the Direct-write Process
We have demonstrated the ability to process a variety of biopolymers into
micro-fibers and branched structures with microvascular-scale diameters by the
direct-write technique using the 3-Axis robotic dispensing system. In order to better
understand the micro-fiber formation mechanism behind the thinning dynamics of
biopolymer solutions, the direct-write process needed to be characterized so that
we can find out what process factors affected the micro-fiber yield and diameter.
An empirical model generated from the characterization process could reveal the
correlation among the fiber diameter to polymer solution properties and system
process parameters. The empirical model also may offer future users the ability to
employ the 3-Axis robotic dispensing system to direct-write micro-fibers without
trial-and-error work. The empirical model was validated by comparing the
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prediction and experimental value of the diameters of the micro-fibers of various
biopolymers other than gelatin.

4.2.1 Characterization of the Direct-write Process
4.2.1.1 Process Factors Reduction
There are eleven controllable variables involved in the direct-write process
(Figure 4.11). The factors highlighted in orange are the solution physical
properties, whereas those highlighted in blue are the process factors defined by
the 3-Axis robotic dispensing system. Investigating all of these variables at once
would result in a model with a large amount of uncertainty; thus, some variables
must be set as constants. Based on the direct-write experiences from our group,
valve pressure (15 psi) and dispensing time (0.2 seconds) were set as constant
for the maximum performance of this system.

Figure 4. 11 Controllable factors involved in the direct-write process
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Before the fiber was drawn, the polymer drop’s size (D0) is critical because
it could be used to define the needle/substrate gap (Figure 3.28) and calculate the
aspect ratio (𝛬) for dimensional analysis (Equation 3-11). Figure 4.12 and Table
4.5 present the D0 measurements of the 16% gelatin solution with different needles
(0.25 mm, 0.20 mm, 0.15 mm, and 0.10 mm) and valve open time (0.02 s, 0.05 s,
0.1 s, and 0.5 s) under constant valve pressure (15 psi). Valve open time (0.1
second) was selected for the future drawing to reduce the system complexity and
further define the needle/substrate gap.

Figure 4. 12 Optical images of the gelatin solution drops with different needles and
valve open time
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Table 4. 5 Gelatin polymer drop diameter measurements
Polymer Drop Diameter (µm)

Valve Open
time (s)
0.02 s

0.05 s

0.1 s

0.5 s

0.25 (red)

460.9 ± 15.1

482.7 ± 4.3

548.1 ± 7.9

622.0 ± 11.3

0.20 (clear)

433.0 ± 3.8

454.2 ± 10.6

484.4 ± 13.9

539.6 ± 9.8

0.10 (lavender)

391.9 ± 7.1

417.8 ± 13.5

435. 5 ± 7.2

444.4 ± 18.8

0.10 (yellow)

365.8 ± 12.8

404.0 ± 15.3

371.8 ± 12.3

394.1 ± 12.9

Needle ID (mm)

In Figure 4.13, it is demonstrated how the needle/substrate gap could affect
the contact between the polymer droplet and the substrate. When the gap was too
small (second images for each needle), it was found that the polymer droplet would
cause fouling outside of the needle. The fouling causes difficulty in producing a
continuous direct-write series of fibers. If the gap was too big (fourth images for
each needle), most of the fiber failed because the minimal contact reduces the
adhesion between the polymer droplet and

the substrate. The ideal

needle/substrate gap was shown in the third images for each needle: 400 µm for
the red needle, 300 µm for the clear needle, 250 µm for the lavender needle, and
200 µm for the yellow needle.
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Figure 4. 13 Optical images of direct-write polymer droplet with differing
needle/substrate distances across different needle inner diameters. A) 0.25 mm,
B) 0.20 mm, C) 0.15 mm, and D) 0.10 mm

4.2.1.2 Design of Experiments
After reducing the number of variables, the significance of the physical
properties of the solution and machine process factors were investigated by
utilizing an unbalanced four factors multi-level full factorial design of experiment.
Arrays of gelatin micro-fibers were fabricated on the substrate using the 3-Axis
robotic dispensing system from different combinations. Figure 4.14 presents an
example of how to measure the fiber diameter through the SEM. The diameters of
each fiber were measured and recorded at the middle point as well as 200 µm from
the initiating and terminating side, and the average value was used as the final
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fiber diameter. Examples of gelatin fibers in different diameters range are shown
in Figure 4.15.

Figure 4. 14 Example of measuring the diameter of the micro-fiber from the fibers
array by the SEM.

Figure 4. 15 SEM images of gelatin fibers with different fiber diameters from the
DOE: A) <1 µm, B) 1-5 µm, C) 5-10 µm, D) 10-20 µm, E) 20-30 µm, and F) >40
µm
128

Statistical analysis of the experimental data has been done using an
ANOVA. ANOVA enables us to gain insight into the direct-write process by
distinguishing which factors have significant effects on the mean fiber diameter.
The ANOVA table for fiber diameters is shown in Table 4.6. The “main effects”
plots of the mean fiber diameter as a function of four different factors are presented
in Figure 4.16. We can see that all four selected factors are significant for fiber
diameters (p = 0.000). Generally, the mean fiber diameters increased with
increasing solution concentration and the needle’s inner diameters and decreasing
feed rate and fiber length. The solution concentration could further affect three
measurable physical properties: viscosity, surface tension, and mass transfer
coefficient; thus, the more accurate fiber diameter correlation will be illustrated in
the empirical model section later.
Table 4. 6 The ANOVA table for fiber diameters
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Figure 4. 16 The “main effects” plots of the mean of fiber diameter as a function of
concentration (%), needle ID (mm), feed rate (mm/s), and fiber length (mm)

The effects of these four factors on the fiber yield are presented in Figure
4.17. Figure 4.17A suggests the 16% gelatin solution has a higher yield (~79%)
compared to 15% and 17%. Figure 4.17B shows that the fiber yield increased with
the increasing needle’s inner diameter due to the enlarged initial polymer droplet
diameter (D0). The feed rate also significantly affects the fiber yield (Figure 4.17C).
Fiber drawn at 200 mm/s shows the highest yield (~77%), while feed rates that are
too slow or too fast will both decrease the fiber yield. Figure 4.17D illustrates the
relationship between the fiber yield and the fiber length. This general trend
suggests that at a shorter length (<8mm), the fiber yield remained at a high level
(>88%). However, as the fiber length increased, the fiber yield dropped
dramatically.
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Figure 4. 17 Yield of direct-writing gelatin fibers versus several factors: A)
concentration (%), B) needle inner diameter (mm), C) feed rate (mm/s), and D)
fiber length (mm).
The DOE indicates that several requirements need to be met to fabricate
micro-fibers successfully with the direct-write method. First, rheological properties
of the solution should be appropriately examined. During the drawing process, the
appropriate choice in solution concentration and needle size ensures that the
solution has sufficient surface tension to achieve the necking effect, enough
viscosity to resist capillary breakup, and proper volatility to promote solidification
of the fiber. Second, the drawing process factors also should be finely tuned. The
proper workable feed rate and fiber length ensures either the drawing velocity is
not too fast to avoid uncompleted surface tension-driven thinning and the fiber is
not too long to cause excessive thinning, resulting in probable breakup.
131

4.2.2 Generation of the Empirical Model
4.2.2.1 Characterization of Gelatin Solution
The physical properties of the gelatin solutions are summarized in Table
4.7. The one-way ANOVA results illustrate both the viscosity and surface tension
of the gelatin solution significantly increase with increasing gelation concentration
(p < 0.001).The mass transfer coefficient is independent of concentration due to
the same solvent and solution/air interface area.
Table 4. 7 Physical properties of the gelatin solutions
Concentration

Viscosity,

Surface tension,

Mass transfer

(wt.%)

η (Pa*s)

σ (mN/m)

coef., χ (m/s)

15

0.93 ± 0.08

27.52 ± 0.46

2.36E-07

16

1.12 ± 0.11

30.50 ± 1.22

2.36E-07

17

1.70 ± 0.04

39.18 ± 0.80

2.36E-07

The gelatin on dry status is a long chain of polymer molecules, which coil
and associate with each other through specific, cooperative, non-covalent junction
zones. Strictly speaking, the solution should be a non-Newtonian fluid. However,
Stainsby et al. firstly pointed out that a concentrated gelation solution behaved like
a Newtonian fluid at a temperature above the gel point[203]. We could estimate
the apparent shear rate at the needle wall by approximating the solution as
Newtonian fluids and adopting the equation as below:
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𝛾′ =

4𝑄
𝜋𝑅 3

(4-1)

Where 𝛾’ is the apparent shear rate at the needle wall, Q is the volumetric
flow rate, and R is the inner radius of the needle. Figure 4.18 shows the
relationship between shear rate and viscosity for gelatin solutions with different
concentrations. The viscosity remains constant with the various shear rate from
~0.1 to ~200 s-1. During the direct write process, the typical flow rate was ~0.68
mL h-1 to ~3.70 mL h-1 and the calculated shear rates were approximately ~15-83
s-1 (the region between the red dotted lines). Based on the results, it was confirmed
that the gelatin solutions conform to the assumption of Newtonian-like fluid during
the direct-write process and, thus, the assumption could be used for dimensionless
model generation.
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Figure 4. 18 The viscosity of gelatin solutions under different shear rates

4.2.2.2 Dimensional Analysis for Empirical Model Generation
The dimensional analysis is employed to obtain a certain set of information
about a given physical issue. Through the dimensional analysis, we can reduce
the multifaceted nature of a physical problem by removing variables that have
limited influence on the given issue. In section 3.3.3.1, we introduced the
Buckingham Pi theorem and showed how to group six parameters into three
dimensionless parameters by selecting MLt (mass, length, and time) dimensions.
The factors, symbols, and dimensions of the process factors used for the
development of the empirical model are shown in Table 4.8. The dimensionless
parameters P and Ca (Table 4.9) were calculated from the polymer solution
physical properties in Table 4.7 by using Equations 3-7 and 3-10. The Aspect
ratio (𝛬) was calculated from the polymer droplet diameter in Table 4.5 by using
Equation 3-11. The values range from 7.30-72.99 based on the different fiber
lengths (2 -40 mm).
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Table 4. 8 Factors, symbols, and dimensions of the response, process factors, and
the dimensionless parameters

Response

Process
Factors

Dimensionless
Parameters

Factors

Symbol

Dimensions

Fiber diameters

D∞

[L]

Viscosity

η

[ ML-1T-1]

Surface tension

σ

[ MT-2 ]

Mass transfer coefficient

χ

[ LT-1 ]

Feed rate

U

[ LT-1 ]

Fiber length

L

[L]

Processability parameter

P

-

Capillary Number

Ca

-

Aspect ratio

Λ

-

Table 4. 9 Calculated dimensionless parameters of the gelatin solutions
Concentration
P
(wt.%)

Ca @

Ca @

Ca @

100mm/s

200mm/s

300mm/s

15

7.98E-06

3.38

6.76

10.14

16

8.67E-06

3.67

7.34

11.02

17

1.02E-05

4.34

8.68

13.02
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A regression analysis was employed on the calculated dimensionless
parameters using Minitab to generate the empirical model. The Box-Cox
transformation was performed on the regression model to ensure accuracy was
maintained. A second order polynomial regression was selected based on the
highest adjusted R2 (86.73%) to avoid overfitting. The formed regression equation
in terms of three dimensionless parameters is shown in Equation 4-2:

(𝐷𝑡 )0.085 = 878006𝑃 − 431617577200𝑃2 − 0.00561𝐶𝑎 +
0.000186𝐶𝑎 2 − 0.003251𝛬 + 0.00012𝛬2 − 3.094

(4-2)

The ANOVA for the transformed response is given in Table 4.10. The “main
effects” plots of the mean of fiber diameter as a function of the three dimensionless
parameters are presented in Figure 4.19. Also, three surface graphs are also
plotted to visualize the effects of the dimensionless parameters. Figure 4.20
demonstrates the trend of fiber diameters in terms of variations in the
dimensionless parameters. The surface graphs were produced by plotting two
variables on the X and Y axis and the other held at their mean level. The results
indicate that both the Processability parameter and Aspect ratio are significant
factors (p = 0.000). The fiber diameter increased with the increasing Processability
parameters, suggesting the combination of low surface tension, high viscosity, and
solvent evaporation rate could cause the polymer to resist the thinning process to
form a larger fiber. Also, it was discovered that the fiber diameter decreased with
the increasing Aspect ratio; the small polymer droplet and long fiber length will
prompt the thinning process, forming a smaller fiber. The Capillary number also
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affected the fiber formation with a significance of p = 0.0012. The Capillary number
accounts for the non-instantaneous nature of the direct-write method from the
robotic dispensing system. A higher Ca indicates that drawing is too fast to allow
the surface-tension-driven thinning to complete. In contrast, lower Ca illustrates
that excessive thinning may occur during the drawing and results in a probable
breakup.

Table 4. 10 The ANOVA for the transformed response of the empirical model
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Main Effects Plot for Fiber diameter (µm)
Fitted Means
18

Processability parameters

Capillary number

Aspect ratio
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Figure 4. 19 The “main effects” plots of the mean of fiber diameter as a function of
Processability parameter, Capillary number, and Aspect ratio.
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Figure 4. 20 Surface plots representing the fiber diameter as a function of A)
Aspect ratio and Capillary number; B) Processability parameters and Capillary
number, and C) Aspect ratio and Processability parameters.

The adequacy of the linear regression analysis was checked by residual
plots in Figure 4.21. First, the normal probability plot and histogram confirmed that
the residuals from the empirical model are approximately randomly distributed. The
residuals against fitted values and observation order showed that each residual
value is independent from each other.
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Figure 4. 21 Plots of the normal probability and histogram of residuals, as well as
residuals against the fitted value and observation order

4.2.3 Validation of the Empirical Equation
The empirical model was generated from the DOE of gelatin solutions in
TFE and revealed the correlation between the micro-fiber diameter, the physical
properties of the polymer solution, and the direct-write process factors. Since the
polymers are a series of long-chain molecules and their solution could be
expressed with similar fundamental physical properties, we assume the empirical
model could be adopted to predict the diameters of direct-write micro-fibers from
other polymer/solvent systems. To test this assumption, we utilized the 3-Axis
robotic dispensing system to process various biopolymers into a micro-fiber array.
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The experimental data of the micro-fiber diameters was obtained and compared
with the value predicted by the empirical model.
Biopolymers in Table 3.4 were fabricated into a micro-fiber array with fiber
lengths of 4, 6, and 8 mm (three fibers for each length). The yield of those microfibers is shown in Figure 4.22. The yield for most of the produced biopolymer
surpassed 65%. However, the yield of 18 wt.% and 19wt. % gelatin/PLGA (50:50)
solution were 32% and 22%, respectively. The same situation was observed in
PLA-PEG (70:30) copolymer fiber; the yield for 30 wt.% and 31 wt.% solution were
only 11% and 22%, respectively. We speculate that the combined low viscosity
and high surface tension caused the capillary breakup. In addition, the solvent
used in the PLA-PEG copolymer is chloroform, which has a lower boiling point than
TFE. The solvent would gradually evaporate in the polymer barrel because it is not
air-tight. The relatively high volatility may increase the actual concentration of the
polymer solution as time passed, leading to the low yield.
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Figure 4. 22 The micro-fiber yield of various direct-written biopolymers
The physical properties of various biopolymer solutions were measured
following the previously described method in Chapter 3. The results are presented
in Table 4.11. Next, the dimensionless parameters were calculated based on the
obtained physical properties and the process factors (Table 4.12). Then, the
calculated dimensionless parameters were used in conjunction with the empirical
model (Equation 4.2) to calculate the predicted micro-fiber diameters. Although
all the biopolymers solutions could be processed to micro-fibers through the 3-Axis
robotic dispensing system, not all the experimental data could be substituted into
the model to get the prediction value due to the biopolymers’ Processability
parameters are excess of exceeding the empirical model range. The distribution
of the Processability parameters of the various biopolymers’ solution is shown in
Figure 4.23. The space between the two orange lines in Figure 4.23 indicates the
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empirical model boundary (~7-13 x10-6), while the Processability parameters of the
solutions of 18 % Gelatin/PLGA (70:30) composites, 28% PLA, 29% PLA, 32%
PLA-PEG (70:30), and 33% PLA-PEG (70:30) copolymers are outside of the
boundary. Thus, the predictions for those biopolymers are excluded from the
empirical model validation.
Table 4. 11 Physical properties of various biopolymers solutions

Concentration

Viscosity, η

(wt.%)

(Pa*s)

Surface

Mass transfer

tension, σ

coef., χ

(mN/m)

(m/s)

25% PLGA

2.12 ± 0.14

45.55 ± 1.59

2.40E-07

26% PLGA

2.84 ± 0.29

65.33 ± 3.23

2.40E-07

17% Gelatin/PLGA(70:30)

1.02 ± 0.06

35.17 ± 2.11

2.54E-07

18% Gelatin/PLGA(70:30)

1.98 ± 0.11

39.98 ± 0.92

2.49E-07

18% Gelatin/PLGA(50:50)

0.88 ± 0.02

56.03 ± 2.43

2.31E-07

19% Gelatin/PLGA(50:50)

1.38 ± 0.16

36.03 ± 2.43

2.26E-07

28% PLA

2.57 ± 0.08

51.23 ± 2.66

4.89E-07

29% PLA

3.01 ± 0.26

49.48 ± 1.77

4.83E-07

20% PLA/PEG(75:25)

0.98 ± 0.04

29.88 ± 0.82

3.14E-07

21% PLA/PEG(75:25)

1.23 ±0.15

30.54 ± 1.24

3.14E-07

30% PLA/PEG(70:30)

0.49 ± 0.20

58.87 ± 2.88

3.14E-07

31% PLA/PEG(70:30)

0.66 ± 0.17

61.41 ± 3.15

3.14E-07
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Table 4. 12 Calculated dimensionless parameters of various biopolymer solutions
Concentration
P

Ca

(wt.%)

Λ

Λ

Λ

(4mm) (6mm) (8mm)

25% PLGA

1.12E-05

9.31

7.63

11.45

15.27

26% PLGA

1.04E-05

8.69

8.21

12.32

16.43

17% Gelatin/PLGA(70:30)

7.37E-06

5.80

7.35

11.03

14.71

18% Gelatin/PLGA(70:30)

1.23E-05

9.90

7.77

11.65

15.53

18% Gelatin/PLGA(50:50)

3.63E-06

3.14

6.81

10.22

13.63

19% Gelatin/PLGA(50:50)

8.66E-06

7.66

7.72

11.58

15.44

28% PLA

2.45E-05

10.03

9.26

13.89

18.52

29% PLA

2.94E-05

12.17

12.38

18.58

24.77

20% PLA/PEG(75:25)

1.03E-05

6.56

7.35

11.03

14.71

21% PLA/PEG(75:25)

1.26E-05

8.06

7.97

11.95

15.94

30% PLA/PEG(70:30)

2.61E-06

1.66

6.69

10.03

13.38

31% PLA/PEG(70:30)

3.37E-06

2.15

7.21

10.81

14.41
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Figure 4. 23 The distribution of the Processability parameters of various
biopolymers

The micro-fiber diameters were measured through the SEM as we
introduced in section 4.2.1.2. The predicted values were obtained from Minitab by
substituting all the calculated dimensionless parameters into the generated model.
The experimental and predicted diameters of micro-fibers with lengths of 4, 6, and
8 mm for the selected biopolymers are presented in Figure 4.24. Generally, the
micro-fiber diameter decreased with increasing fiber length. Also, there is a
noticeable trend of the micro-fiber diameter increasing with the increasing
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biopolymer solution concentration. The result is consistent with the previously
made conclusion that we made earlier in the gelatin fiber characterization process.

Figure 4. 24 Comparison of the predicted and the experimental diameters of the
direct-write micro-fibers for various biopolymers, composites, and copolymers
(micro-fiber length of 4, 6, and 8 mm)
Finally, we used three measures to evaluate the performance of the
prediction of the empirical model. The measures are presented in Table 4.13:
mean absolute deviation (MAD), mean squared deviation (MSD), and the mean
absolute percentage error (MAPE). The mean absolute error and mean absolute
percentage error for all validation is 5.77 µm and 51.28%, respectively.
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Table 4. 13 Measurement of the prediction error
Length

MAD (µm)

MSD (µm2)

MAPE (%)

4 mm

6.65

75.70

46.61

6 mm

5.51

50.34

47.98

8 mm

5.15

48.80

59.25

Average

5.77

58.28

51.28

4.3 Direct-write Microvascular Scaffold for Endothelial Cells Morphogenesis
4.3.1 Biopolymer Selection for Scaffold
4.3.1.1 Biodegradation Test
From our preliminary cell culture experiments, we found that the gelatin and
gelatin/PLGA composites were still water soluble. If made of these polymers, most
of the fabricated scaffold will be totally dissolved in the cell medium at 37 C
̊ within
less than 2 hours. Thus, crosslinking of the gelatin and gelatin/PLGA composites
was performed to improve the water-resistant ability of the micro-fibers. After
comparing

common

crosslink

methods

such

as

oxygen

species

and

glyceraldehyde solutions, the vapor-phase glutaraldehyde method was selected
because this is the only method that will not significantly increase the micro-fibers
diameters[204]. Therefore, in this experiment, all the gelatin and gelatin/PLGA
composites samples were treated with glutaraldehyde vapor (50%) for 3 hours in
a sealed desiccator at room temperature. PLA-PEG (60:40) and PLA-PEG (50:50)
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were not evaluated in this test because they cannot be processed into micro-fibers
through the 3-Axis robotic dispensing system.
The samples of the studied biopolymers underwent the biodegradation test
in the PBS solution at 37 C
̊ simulating in vivo conditions. Figure 4.25 shows the
biodegradation profiles for various biopolymers. The pure PLA showed the lowest
degradation rate, more than 85% of the weight remained after 8 weeks. However,
the PLA-PEG copolymers showed a much higher degradation rate compared to
PLA. The PLA-PEG (90:10) and PLA-PEG (75:25) copolymers had 76% and 47%
of the sample weight remaining, respectively. It should be noted that the PLA-PEG
(70:30) broken into small pieces in 4-5 weeks. The reason the copolymer had a
higher degradation rate is that the ester bonds formed in the copolymer are broken
much easier due to a hydrolytic reaction. It can also be observed that the
crosslinked gelatin

withstood the aqueous environment more rigorously than

traditional gelatin, with 36% weight loss measured at the end of the experiment.
The PLGA degrades slowly, showing a 16% weight loss. The gelatin/PLGA
composites exhibited a moderate degradation rate that was between the rate of
the PLGA and gelatin samples. The two composites were observed to break into
small pieces after 6 weeks. In summary, although the improvement of the
degradation was not ideal , both the composites and copolymers could increase
the degradation rate compared to the pure PLA and PLGA. According to this
experiment, the crosslinked gelatin, PLA-PEG (75-25), and PLA-PEG(70:30) are
all potential scaffold candidates.
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Figure 4. 25 The degradation profile for various biopolymers, composites, and
copolymers. Gelatin and gelatin/PLGA were all crosslinked by glutaraldehyde
vapor. Error bars were not shown for clear visualization. X represents that the
polymer cubes broke into small pieces.
4.3.1.2 Biopolymers Cellular Adhesion and Viability Test
After evaluating the biopolymer’s degradation ability, it is important to
examine if the biopolymers are suited for the HDMECs growth. The cellular
adhesion potential of the biopolymers and the viability test results are presented in
Figure 4.26. The green and red color represent the live cells and dead cells,
respectively. It could be seen that only a few viable cells were detected in the
crosslinked gelatin and gelatin/PLGA composites. One possible reason for this is
the toxicity of the crosslinking agent – glutaraldehyde. It has been reported that the
potential source of cytotoxicity of the crosslinker may be residue of unreacted
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crosslinking agent that leaches into the cell media. We also initially speculated that
the cytotoxicity may be a result of the solvent TFE. However, this speculation could
be ruled out because the PLGA dissolved in TFE (not treated by the glutaraldehyde
vapor) possesses a much higher viable cell count. The PLA and PLA-PEG
copolymers generally showed high cell viability. Although the PLA-PEG
copolymers with improved hydrophilicity were expected to grow more cells than
PLA, we observed that the attached cell count for the copolymers was less than
the PLA; the attached cell count decreased with increasing the content of PEG
segments in the copolymer. This trend has also been reported before: PEG
segments could reduce the binding of proteins and cell adhesion on the material
surface[205]. Thus, PLGA, PLA, and PLA-PEG copolymers are all potential
biopolymers for the HDMECs seeding and growth.
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Figure 4. 26 Cellular adhesion and viability profiles for various biopolymers
Considering the multiple factors involved in the direct-write yield, the
biodegradation

rate,

and

the

HDMECs

adhesion

ability

and

viability

comprehensively, the PLA-PEG (75:25) copolymer was selected for the
microvascular scaffold study.

4.3.2 Cell Seeding Conditions
4.3.2.1 BSA Coating Experiment
A critical goal of this project is to ensure the HDMECs could adhere to the
suspended scaffold and proliferate on it. Besides the gentle rocking of the well
plate to increase the possibility that the suspending cells could contact the scaffold,
we could also block the bottom of the well plate. The BSA coating has proved to
be one of the efficient ways to avoid cell adhesion on the bottom on the well plate
for HUVECs[201]. Figure 4.27 shows the blocking effects of different
concentrations of the BSA coating for HDMEC cell adhesion. It can be concluded
that the BSA coating significantly reduced the cells number that attached on the
bottom of the well plate (p < 0.002). The result also indicated that the concentration
of BSA did not influence the blocking of the HDMECs, possible because that even
the BSA solution with concentration as low as 0.01% was enough to form a uniform
anti-fouling layer on the bottom of the 24-welll plate and prevent the HDMECs
adhesion.
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Figure 4. 27 The comparison of cell density on the bottom of the well plate after
applying a BSA coating at different concentrations

4.3.2.2 Adhesion Promoters Comparison
In order to further enhance the adhesion of the HDMECs on the surface of
the scaffold, adhesion promoters such as gelatin-based attachment factor (AF) and
fibronectin (FN) were applied on both PLA-PEG (75:25) copolymer films and microfibers. Figure 4.28 displays the fluorescent images (nuclei with DAPI) of the
HDMECs adhered on the copolymer films and micro-fibers with different adhesion
promoters. The statistical result is presented in Figure 4.29. With the surface
modifications of AF, FN, and their combination, the attached cells number on the
films had a higher cell count than the non-treatment control (p = 0.101, p = 0.030,
and p = 0.044, respectively). It can be observed that the difference in successful
adhesion between the FN and AF+FN treatments is not significant (p = 0.738).
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Figure 4. 28 Fluorescent images of the HDMECs adhered on copolymer films and
micro-fibers with different adhesion promoters

Figure 4. 29 The quantity of attached cells on the copolymer films and micro-fibers
with treatments of different adhesion promoters
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4.3.2.3 Cell Seeding Density Experiment
The preliminary culture experiments indicated that the initial HDMECs
seeding density of approximately 40,000 cells/cm2 was insufficient due to most of
the scaffold only having cells scattered on its surface. According to our seeding
strategy, the suspended cells would randomly adhere and grow on the scaffold
under the influence of gravity and external stimulation, such as rocking. We
anticipate the increasing cell seeding density could improve the output. Figure
4.30A-D shows the fluorescent images of the HDMECs adhered on the copolymer
micro-fibers with a series seeding density: 40,000 cells/cm 2, 60,000 cells/cm2.
80,000 cells/cm2, and 100,000 cells/cm2. Figure 4.30E illustrates the statistical
results of this experiment. It can be seen that when increasing seeding density, the
number of adhered cells on the length of the micro-fiber increased significantly (p
= 0.013, p = 0.001 and p = 0.000, respectively). Although a higher initial seeding
density could obtain a higher cell count on the micro-fiber, the result suggests that
the difference between 80,000 and 100,000 cells/cm 2 is not significant (p = 0.800).
Considering the cost and time involved in culturing cells, we chose the seeding
density of 80,000 cells/cm2 for the future experiment.
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Figure 4. 30 Fluorescent images of the HDMECs adhered on the micro-fiber with
seeding density of A) 40000 cells/cm2, B) 60,000 cells/cm2, C) 80,000 cells/cm2,
and D) 100,000 cells/cm2. E) Differences in the quantity of the attached cells on
the micro-fibers with a different seeding density.

4.3.3 Endothelial Cell Tubulogenesis on Microvascular Scaffold
With the previously obtained optimal seeding conditions, the HDMECs were
successfully seeded on the scaffold and cultured for 48 hours without any addition
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of exogenous growth factors or angiogenic agents. The slice view of the confocal
image of a single PLA-PEG micro-fiber with HDMECs cultured and stained is
presented in Figure 4.31A. As can be seen in this slice view (X-Y view), the cells
preferentially spread along the axial direction of the micro-fiber scaffold. The
scaffold displayed in the figure had a diameter of 12.4 µm, and the average
distance between adjacent cells was 15.1 ± 3.2 µm. The circular shape in the right
of Figure 4.31A is the X-Z view; this image demonstrates the two cells connected
circumferentially around the scaffold and formed a lumen. Figure 4.31B shows the
confocal volume view of the HDMECs covered scaffold. From the 3D view, it can
be observed that the whole surface of the scaffold was covered with the cells along
the axial direction. The inserted cross-sectional image confirmed the confluent
monolayer formation of the HDMECs due to the cells wrapping circumferentially
around the scaffold. In Figure 4.31C-D, the HDMECs demonstrated an elongated
shape on the surface of the three-dimensional branched micro-fiber with an aligned
orientation that was different from the typical two-dimensional spread shape with
random orientation. The morphological change of the cells suggests a distinctive
cellular response to the three-dimensional scaffold. The result also confirmed the
previously reported contact guidance phenomenon whereby the endothelial cells
follow the direction lead of natural or artificial scaffolds architecture to mediate their
morphogenesis and functional differentiation[195].
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Figure 4. 31 Confocal images of a single PLA-PEG fiber with the HDMECs cultured
and stained to highlight the nuclei (blue) and cytoskeletons (red) A) Slice view; B)
Volume View; Fluorescent images of the HDMECs stained to highlight the nuclei
(blue) and actin cytoskeletons (red) at C) the surface of a branched PLA-PEG
scaffold, and D) the bottom of the 24 well plate

In order to further study the physiological characteristics of the HDMECs
growing on the scaffold, immunostaining for vascular endothelial cadherin (VEcadherin) was employed to identify cell-cell junctions. Figure 4.32A presents a
single PLA-PEG copolymer scaffold with its surface covered by the HDMEC
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monolayer. The inserted cross-sectional image confirmed the cells have grown
around the circumference of the scaffold. In Figure 4.32B, the cell-cell junctions
were demonstrated via VE-cadherin expression. Recent findings have uncovered
that endothelial cell-cell junctions play an essential role in maintaining structural
integrity and transferring intracellular signals that determine cell growth, cell
polarity, lumen formation, and interaction with pericytes and smooth muscle
cells[206]. Additionally, the endothelial cell-cell junctions have been involved in
several complex signal transmission that controls the vascular permeability and
barrier function in an adult vessel[207]. The VE-cadherin expression of the
HDMECs on the scaffold demonstrated the neighboring cells adhered to each
other and formed cell-cell junctions. These images also suggest that the cellcovered scaffold strategy has the ability to form a microvascular network in vitro.

Figure 4. 32 Confocal image of a single PLA-PEG fiber with the HDMECs cultured
and stained to highlight the nuclei (blue) and VE-cadherin (green) with a crosssectional image (insert) at 40X magnification A), and B) partial enlargement of (A)
at 60X magnification.
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The HDMECs grown on the PLA-PEG copolymer were imaged at higher
resolution by using the SEM. As illustrated in Figure 4.33A, similar results for the
previous immunostaining confocal images were observed in the SEM images. The
scaffold displayed in the figure had a diameter of 13.1 µm, and the average size of
the HDMECs was 17.6 ± 2.86 µm. After the fixation and dehydration, the HDMECs
were observed to be evenly distributed on the surface of the scaffold. It can also
be observed that the long axial of the elongated cells aligned along the axial
direction of the scaffold. Figure 4.33B-D showed several enlarged images of
connections between adjacent cells (pointed with the red arrow); these images
could further confirm the formation of the cell-cell junctions.
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Figure 4. 33 A) SEM image of a single PLA-PEG fiber with the HDMECs cultured
for 48 hours; B), C), and D) partial enlargements of (A) for cell-cell junctions

In order to determine whether the cells on the surface of the PLA-PEG
scaffold are still alive after two days of culturing, a live/dead assay was utilized to
examine the viability of the HDMECs on the scaffold. Figure 4.34 presents the
fluorescent images with different magnifications: A) 4X, B) 10X, and C) 20X. The
upper row images were captured under the blue filter showing the live cells, and
the lower row images were taken under the green filter showing the dead cells. It
can be seen that the cells on the suspended scaffold are all alive and grew along
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the axial direction of the scaffold. Several dead cells could be observed in the
background, which is the bottom of the 24-well plate at a different focal plane. This
result suggests the cells that cover the scaffold are still active and could be cultured
in the ECM for the further study.

Figure 4. 34 Fluorescent images of the HDMECs stained to highlight the live cells
(Calcein, green, upper row) and dead cells (EthD-1, red, lower row) at different
magnification: A) 4X, B) 10X, and C) 20X

After demonstrating the ability to grow a confluent HDMEC monolayer on
the single PLA-PEG micro-fiber scaffold, the HDMECs were also seeded and
cultured for 48 hours on a PLA-PEG branched structure. The 3D reconstruction
confocal image is presented in Figure 4.35A. It can be seen that the cells were
patterned along the branched structure with topographic guidance. No cell
connections between the neighboring branches were observed, which further
confirmed the cellular orientation response to the three-dimensional scaffold.
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Figure 4.35B shows the partial enlargement of the branched structure; similar
results compared to the previous single micro-fiber scaffold were obtained. The
cells appear to spread along the axial direction on the scaffold and the crosssectional image (inserted) confirmed the cells are tightly enveloping the entire
circumference of the scaffold. The successful formation of HDMECs-covered
branched structures suggests our approach is highly feasible for the construction
of the microvascular network in vitro.

Figure 4. 35 A) 3D reconstruction confocal image of HDEMCs on PLA-PEG
branched structure stained for the nuclei (blue) and actin cytoskeletons (red) at
20X magnification, B) partial enlargement of (A) with a cross-sectional image
(insert) at 40X magnification

4.4. Prevascularization of Hybrid Constructs
We have introduced that collagen, fibrin, and MatrigelTM could be used as
ECM to provide a three-dimensional environment that structurally supports cells
and allows for a diffusion of nutrients. After we successfully obtained the cell162

covered scaffold, we want to further encapsulate it into an ECM to get a
vascularized sheet to allow cells to attach and maintain a lumen shape after the
scaffold is degraded. To demonstrate this conceptual method, we embedded the
cell-covered scaffolds into a 1 mg/mL Type I collagen hydrogel and culture the
hybrid constructs for an additional three days. Figure 4.36A shows the hybrid
structures attached on the acrylic frame (highlighted in the red dot square) after
three days of culture. The vascularized sheet was a soft, semi-transparent, and
moisture-absorbing film. After carefully cutting the four edges of the film, the
vascularized sheet detached from the frame. However, the sheet immediately
twisted and folded due to the internal tension (Figure 4.36C and F, pointed with
the red arrow). Surprisingly, the sheet could unfold itself just by adding a few drops
of PBS solution. As can be seen in Figure 4.36D-E, the vascularized sheet
gradually extended itself under the buoyancy of the PBS solution. Eventually, the
vascularized sheet completely unfolded itself to form a free-standing film that is
floating in the PBS solution. In the classical “bottom-up” approach for the tissue
engineering, the key idea is first to create intermediate “modular tissues” and then
assemble them into the desired engineered tissue[208]. Guided by this strategy,
we added another vascularized sheet into the system and it also unfolded
automatically (Figure 4.36F-H). These two or even more two-dimensional sheets
could be used as the “modular tissues” that are eventually stacked on each other
to form more advanced three-dimensional architecture. Figure 4.36B shows the
vascularized sheet after fixation and dehydration became dry and brittle. It is worth
noting that after a series of graded ethanol washes, the sheet needed to be taken
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out from the frame and transferred to a PTFE substrate before it completely dried.
Otherwise, the sheet will stick to the bottom of the wall plate and will be difficult to
peel off.

Figure 4. 36 Optical images of the vascularized sheets: A) on the custom acrylic
frame, B) after fixation and dehydration, C-E) hybrid structure unfolded itself in the
PBS solution, and F-H) two hybrid structures in the PBS solution.

164

Using fluorescent staining, the inner structure of the vascularized sheet
could be observed and the growth status of the cells in the ECM could be evaluated.
As shown in Figure 4.37A-B, the HDMECs on both a single micro-fiber and a
branched structure scaffold could be seen. Although the images are a bit hazy
(may be caused by the scattering of the fluorescent light in the opaque collagen
gel), we can still confirm that the HDMECs are growing along the axial direction of
the scaffolds. No migrated cells near the scaffold were observed, indicating that
the HDMECs were well attached on the scaffolds with the help of mechanical
support and the diffusion of nutrients aided by the ECM. Figure 4.37C-D shows
the 3D reconstruction confocal images of the hybrid structure. Notably, the inserted
cross-sectional image in Figure 4.37C shows the cells were wrapping the
circumference of the scaffold and the lumen shape was still maintained. Also, the
cells in the 3D confocal images were observed to not migrate from the initial
scaffold. To further evaluate the viability of the cells after they were encapsulated
into the ECM, the live/dead assay was utilized and the results are shown in Figure
4.37E-F. One can see most of the cells on the scaffold were still alive. However, a
few granule-shaped cells and dead cells could be observed, suggesting the cells
may not last long on the scaffold. This behavior may be caused by contact
inhibition, which was often found in the monolayer endothelial cells culture if there
was no chemotactic or mechanical stimuli[209, 210]. Nevertheless, this approach
has the possibility to create a directional microvascular network within the collagen
hydrogel matrix.
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Figure 4. 37 Fluorescent images of a A) single micro-fiber and a B) branched
structure stained for the nuclei (blue) and actin cytoskeletons (red); 3D
reconstruction confocal images of a C) single micro-fiber and a B) branched
stained for the nuclei (blue) and actin cytoskeletons (red); E-F) fluorescent images
of the live/dead assay stained to highlight the live cells (Calcein AM, green) and
dead cells (EthD-1, red).
To examine the microscopic morphology of the hybrid structure, the
dehydrated sheet was cut perpendicular to the direction of the micro-fiber scaffold
by a blade and visualized through the SEM (Figure 4.38A). Figure 4.38B presents
a 106X magnification the SEM image to show the overall perspective of the cross166

sectional cut. Two parallel micro-fiber scaffolds could be identified. Three
distinctive spots were selected to further study the microstructures. The side view
of the hybrid structure is shown in Figure 4.38C. We could see the dehydrated
collagen network is composed of fiber bundles and small pores. The fibrous and
porous microstructure could supply not only mechanical support, but also allow the
diffusion of nutrients to the cells. Figure 4.38D shows the cross-sectional view of
the collagen hydrogel film: the average thickness of the film is approximately 18
µm. We can see the dehydrated film consists of several layers that are
interconnected with small pores. The highly porous microstructure has been shown
to play a critical role in cells proliferation and media diffusion. Figure 4.38E
presents the cross-sectional image of the vascularized sheet. The circular shape
of the scaffold, the fibrous nature of the ECM, and several pieces of cell debris
could be seen from the incision. Figure 4.38F is a sample where the cutting
process accidentally broke the side of the collagen hydrogel. We could see more
intact cells are attached on the scaffold. This image could further confirm that the
vascularized sheet exhibits scaffold-cell-ECM interactions. From these images,
there is still no evidence to suggest the scaffolds have degraded because the
scaffolds are still tightly wrapped in the ECM. Also, the previous degradation
experiments showed that after three days, an obvious mass change of the
biopolymer will not be observed.
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Figure 4. 38 A) Optical image of the dehydrated vascularized sheet after radial
cutting. SEM images of B) an overview of the cross section (106X magnification),
C) side view of the dehydrated ECM (4.39 KX magnification), D) cross-sectional
view of the dehydrated ECM (1.98 KX magnification), and E, F) cross-sectional
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view of the vascularized sheet with scaffold-cell-ECM interaction (6.0 KX
magnification)
In order to further study the scaffold degradation behavior inside of the ECM,
we increased the culture time to two weeks. Figure 4.39 presents the crosssectional views of the vascularized sheet under different culture times. The upper
row images (A1-A3) show several examples of the samples under three days of
culture. Similar to the previous result, the circular-shaped micro-fiber scaffold
(highlighted by the green dashed line) was closely covered by the collagen gel,
and no space could be seen between them. Also, no visible HDMECs were
observed in these views since the connection between the scaffold and collagen
was very tight and the endothelial cells may not have been distinguishable due to
the small cell thickness (500 nm). It is worth noting that most of the samples under
two weeks of culturing were not observed to have obvious scaffold degradation.
The lower images (B1-B3) show several representative examples of vascularized
sheet that have aby indication of scaffold degradation. As can be seen, these
micro-fiber scaffolds showed various cross-sectional shapes, suggesting they
were experienced different degradation degree. For instance, the scaffold in
Figure 4.39B-1 shows an irregular polygon-shaped scaffold and the lumen outline
(highlighted in the red dashed line). The cavity on the scaffold surface may have
been formed by the surface erosion degradation mechanism; the measured crosssectional area ratio of the scaffold and the lumen is approximately 82.3%. In
Figure 4.39B-2, a taper-shaped scaffold with a 44.5% scaffold/lumen outline ratio.
This decrease in ratio may suggest more scaffold materials degraded away in the
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same culturing environment. These differences in degradation may be caused by
both the different diffusion rates within the complex collagen network and unknown
interactions between the ECM, cells, and the scaffold. In Figure 4.39B-3, we
observed a perfect lumen within the

collagen hydrogel without any scaffold

remaining. However, this result does not conform to the previous degradation test
result in which the PLA-PEG (75:25) copolymer was not able to completely
degrade in two weeks. We speculated three reasons as to why the scaffold
degraded in this sample: (1) the scaffold broke or pulled away during the crosssectional cut; (2) the scaffold may have experienced bulk erosion and the debris
was washed away by the media; (3) this sample was left in the desiccator for two
weeks before taking SEM images and the vacuum environment may have caused
the scaffold to detach from the dehydrated collagen gel. The future challenge
involves better understanding the degradation mechanism of the biopolymer
scaffold within the collagen hydrogel, being able to accelerate the hydrolyzation
rate by adding a catalyst or finding a new material with a faster degradation rate to
allow the scaffold to degrade completely in one week.
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Figure 4. 39 SEM images of the cross-sectional view of the vascularized sheets
after: A1-A3) three days culture, B1-B3) two weeks culture
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CHAPTER 5: CONCLUSIONS AND FUTURE DIRECTIONS
The capability to selectively produce microcirculatory vessels is critical to
the emerging field of tissue engineering. In order to produce microvasculature, a
scaffold is required to support and stimulate endothelial cell adhesion and growth.
The primary goal of this project was to develop both a protocol for the construction
of a precisely positioned, three-dimensional, suspended biopolymer scaffold with
varying diameters and a conceptual scaffold-covering strategy to create
physiological microvascular networks in vitro.
In this work, we extended the direct-write technique and adopted the 3-Axis
robotic dispensing system developed by Dr. Scott Berry and Dr. Hanwen Yuan,
who previously worked in our laboratory. Gelatin, PLGA, Gelatin/PLGA composites,
PLA, PLA-PEG copolymers were successfully processed into precisely-positioned,
suspended micro-fibers and branched structures. The geometries of the microfibers and the branched structures were successfully controlled during fabrication
to match the microvascular-scale (5 - 40 µm). We have demonstrated the ability to
control the spatial orientation of the branched structures and the relative errors for
the actual and design branching angles were less than 9%. We also demonstrated
the ability to develop the branched structures with varying diameters so that they
could better mimic the real capillary system structure of arterioles, capillaries, and
venules. Moreover, several complex structures such as web structure with multiintersections, parallel fiber array, and overlapping fibers with the orthotropic
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structure were also successfully fabricated by precisely controlling the dispensing
tip to move between the predefined spatial spots.
In addition to fabricating the biopolymer micro-fibers, we expected to better
understand the fiber formation mechanism behind the thinning dynamics of
biopolymer solutions as well as determine what process factors affected the microfiber yield and diameter. The direct-write process was characterized by a single
polymer/solvent system (gelatin/TFE) through the unbalanced four factors multilevel full factorial design of experiment. Biopolymer solutions’ concentration,
needle’s inner diameter, feed rate, and fiber length were confirmed as the
significant factors that could both affect fiber yield and diameters (p = 0.000 for
both). Next, a dimensional analysis was performed to reduce the 6 physical
variables to 3 dimensionless parameters, followed by the employment of a linear
regression analysis to generate an empirical model based on the dimensionless
parameters. This empirical model revealed the correlation between the fiber
diameter, polymer solution properties, and system process parameters. Then, the
empirical model was validated by various biopolymer/solvents systems and the
predicted and experimental data of micro-fibers diameters was compared. By
excluding the out-of-boundary data, the mean absolute deviation was 4.30 µm,
and the mean absolute percentage error was 38.22%.
After

considering

the

multi-factors

of

the

direct-write

yield,

the

biodegradation rate, and the endothelial cells adhesion ability and viability
comprehensively, the PLA-PEG (75:25) copolymer was selected to be seeded with
HDMECs. The optimized seeding conditions were as follow: (1) the bottom of the
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24-well plate was blocked by 0.01% BSA solution; (2) the scaffold was surface
modified by 5 µg/mL fibronectin solution; (3) a seeding density of 80,000 cells/cm2
was selected. The HDMECs cultured on suspended scaffolds were observed to be
living on the surface of the three-dimensional branched structures and had an
elongated shape with an aligned orientation. The 3D reconstructed confocal
images confirmed the HDMECs proliferated both along the axis and around the
circumference of the micro-fibers and to create a confluent monolayer of cells on
the surface of the micro-fiber. The VE-cadherin expression of the HDMECs
demonstrated the neighboring cells adhered to each other and formed cell-cell
junctions.
The last step for the scaffold-covering strategy is to encapsulate the cellcovered scaffold into the ECM and let the scaffold degrade through hydrolysis. In
this study, we successfully embedded the cell-covered scaffold into a collagen gel
and cultured for three additional days. The fluorescent and confocal images
showed the viable cells were still wrapped on the scaffold and maintained the
cylinder-shaped monolayer. The cross-sectional SEM images confirmed the ECMcell-scaffold interactions. No visible scaffold degradation was observed after three
days of culture, while a few samples showed obvious mass loss (17.7% - 55.5%)
after two weeks of culture through the cross-sectional images. Although the
scaffold was not completely degraded as we expected in this study, we
demonstrate the ability to obtain a flexible and free-standing “modular tissue,”
which could be potentially assembled to a 3D microvascular network in the future
work.
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In this dissertation, we developed the proof-of-concept scaffold-covering
strategy to create a microvascular network with the direct-write scaffold method in
vitro. Based on the present progress and current understanding of the formation
mechanism of the microvasculature, the following recommendations are made
with respect to future work:
(1) Develop a new biodegradable polymer with a faster degradation rate
(less than a week) which could be direct-written as well. For the PLA-PEG
copolymer, a polymerization catalyst such as stannous octoate could be used to
prompt the reaction rate and increase the ester bond ratio, therefore accelerating
the hydrolysis process[205].
(2) A co-culture system could have potential in the construction of
microvascular systems, specifically enhancing the cell lumen integrity and viability.
Supporting cells could include pericytes, vascular smooth muscle cells, and
mesenchymal cell[211].
(3) Further experimentation should be conducted to gain insight into the
utilization of specific growth factors such vascular endothelial growth factors,
junctional proteins such as the vascular endothelial cadherin, and extracellular
proteins such as EGF like domain 7 during the capillary system formation
process[212].
(4) Manipulation of external forces–such as cyclic and static strain, as well
as flow-induced shear stress–may help the HDMECs suppress apoptosis,
enabling the cells to survive during the scaffold hydrolysis degradation. These
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external forces may also help to create a perfusable vessel and maintain the lumen
integrity of the cell monolayer.
(5) An in vivo animal study will be beneficial to further evaluate the potential
of “modular tissue” sheets developing into a three-dimensional functional
microvascular network through angiogenesis.
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